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7Abstract
Objectives: To assess the prevalence and risk factor profi les of respiratory 
symptoms, asthma and chronic bronchitis in Helsinki, and to compare 
these results with those for Sweden and Estonia. Other important aims 
were to evaluate the prevalence and determinants of type 1 sensitization 
in Helsinki.
Materials and methods: Th is presentation is a part of a large 
epidemiological study in Finland, Estonia and Sweden (FinEsS). Th e fi rst 
part of the study consisted of a postal questionnaire in 1995–1996 distributed 
to subjects in eight study centres. Th e study population in each centre was 
a population-based random sample designed to be representative of the 
general population. Th e original study sample in Helsinki consisted of 8000 
subjects aged 20–69 years, 6062 (76%) of whom participated. Comparisons 
between countries were based on a narrower age group, 20–64 years, since 
64 years was the upper age limit used in the original study in Estonia. Th us, 
altogether 58 661 subjects aged 20–64 years were invited to participate in 
Finland, Sweden and Estonia, and 44 483 (76%) did so. Th e second part of 
the study was a clinical study with a structured interview, lung function 
measurements and skin-prick tests with 15 common allergens. Th is thesis 
reports only the results of the prick tests in Helsinki. Of the 1200 subjects 
invited to participate in Helsinki, 643 (54%) consented. Skin-prick tests 
were performed on subjects ≤ 60 years of age; thus, a total of 498 tests were 
done.
Results: In Helsinki, the prevalence of physician-diagnosed asthma was 
6.6% and of physician-diagnosed chronic bronchitis 3.7% among subjects 
aged 20–69 years. Comparison of the results between Finland, Sweden 
and Estonia in subjects 20–64 years of age revealed the highest prevalence 
of physician-diagnosed asthma in Sweden, 7.8%, while the prevalence in 
Finland was 5.9% and in Estonia 2.0% (p<0.001). Th e prevalence of physician-
diagnosed asthma among those aged 20–29 years was 7.9% in Stockholm, 
6.3% in Helsinki and 2.8% in Tallinn. Asthma-related symptoms were most 
common in Estonia, and among those with typical asthma symptoms the 
diagnosis of asthma was least likely in Estonia. Physician-diagnosed chronic 
bronchitis was reported to be 10.7% in Estonia, 3.1% in Sweden and 2.9% in 
Finland among subjects aged 20–64 years (p<0.001). Among those aged 20–
29 years, 7.6% in Tallinn reported physician-diagnosed chronic bronchitis, 
while the prevalence estimates were 1.4% in Stockholm and 1.3% in Helsinki. 
Th e prevalence of smoking was similar for women in all three countries, 
around 30%, but large diff erences in smoking habits were present among 
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8men; 60% of Estonian, 39% of Finnish and 28% of Swedish men smoked. 
Skin-prick tests in Helsinki revealed a high prevalence of sensitization, 
46.9%. For subjects aged 26–39 years, the prevalence was highest, 56.8%, and 
23.7% were sensitized to at least four allergens. Th e most common sensitizing 
allergen was the dog. Sensitization to multiple allergens was associated with 
a high prevalence of asthma and allergic rhinitis.
Conclusions: Compared with earlier Finnish studies, a higher prevalence 
of asthma and a lower prevalence of chronic bronchitis were found in 
Helsinki. Th e prevalence of physician-diagnosed chronic bronchitis was low 
in Helsinki, with only one-fi ft h of subjects fulfi lling the symptom criteria for 
chronic bronchitis reporting having a diagnosis of chronic bronchitis. Th e 
prevalences of asthma and chronic bronchitis were similar in Finland and 
Sweden, but in Estonia physician-diagnosed asthma was less common and 
physician-diagnosed chronic bronchitis more common, particularly among 
young subjects. Further analyses revealed that the diagnosis of asthma was 
favoured in Finland and Sweden, while the diagnosis of chronic bronchitis 
was more likely in Estonia for subjects with the same symptoms. Allergic 
sensitization was common in Helsinki. Our fi ndings of multiple sensitization 
also speak in favour of evaluating the degree of sensitization when assessing 
allergies.
Abstract
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1 Introduction
Asthma and allergic sensitization have increased in prevalence during the 
second half of the last century. Th is increase has been well documented 
all over the world in Westernized communities. Th e highest prevalence 
estimates of asthma have been found in English-speaking countries. Two 
worldwide population studies have focused on this phenomenon: the ECRHS 
(European Community Respiratory Health Survey) in adults and the ISAAC 
(International Study of Asthma and Allergies in Childhood) in children.
A pandemia of chronic obstructive pulmonary disease (COPD) has also 
been predicted due to the increasing prevalence of smoking. However, the 
smoking habits in the Nordic countries show the opposite trend. WHO 
(World Health Organization) has predicted COPD to be the third commonest 
cause of death by the year 2020.
Many Nordic countries have long traditions of respiratory epidemiological 
studies. Denmark, Iceland, Norway and Sweden have participated in the 
ECRHS. Sweden participated in the ISAAC as well. Finland participated 
in the ISAAC, but not in the ECRHS. Major epidemiological studies on 
obstructive airway diseases in the Nordic countries consist of the OLIN 
(Obstructive Lung Disease in Northern Sweden) study in Sweden, the 
Bergen-Hordaland studies in Norway and the Copenhagen City Heart Study 
in Denmark. Estonia took part in both ECRHS and ISAAC.
In Finland, population-based large respiratory epidemiological studies 
in adults date back to the 1960s and 1970s, when Huhti (1965) performed 
his studies on chronic bronchitis, and Alanko (1970) on asthma. At that 
time, the prevalence of asthma was low, 1.4%, whereas the prevalence of 
chronic bronchitis was high, 27% among men and 5.5% among women. Since 
then cohort studies in farmers, conscripts, students and elderly population 
have been performed, but no large population-based cross-sectional or 
longitudinal studies have been carried out on obstructive airway diseases. 
Large changes in the epidemiology of obstructive airway diseases and 
allergic sensitization occurring between the 1960s and 1990s warranted an 
epidemiological study in Finland.
Th e FinEsS studies started in 1995 in three neighbouring countries, 
Finland, Estonia and Sweden. Th e primary objective was to assess the 
prevalence of respiratory symptoms, asthma, chronic bronchitis, and 
allergic sensitization. Th e fi rst part of the study aimed to give a description 
of demographic data in order to calculate risk factors for symptoms and 
diseases by using a postal questionnaire. Th e second part consisted of a 
structured interview and clinical examinations to evaluate the prevalence of 
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obstructive airway diseases using clinical criteria, to measure the proportion 
and degree of impaired lung function in the general population, to assess 
the prevalence of allergic sensitization and to examine new methods for 
diff erential diagnosis as well as early detection of obstructive airway diseases. 
Th e use of validated questions and the same clinical methods allowed us to 
compare results between countries.
Th is thesis focuses on the fi rst part of the FinEsS studies, describing 
the results for Helsinki and comparing Helsinki to both Stockholm and 
Tallinn. Pooled data of all centres are analysed, focusing on risk factors and 
diagnostic diff erences. Comparison of diagnostic practices is achieved by 
comparing respiratory symptoms with the diagnoses of asthma and chronic 
bronchitis obtained in diff erent countries. Data on allergic sensitization in 
Helsinki are also presented.
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2 Background
2.1 Epidemiology and diagnosis of asthma
2.1.1 Defi ning asthma in epidemiological studies
Th e aim in epidemiological studies on asthma is to refl ect the clinical picture 
of asthma as accurately as possible. Th ese studies are challenging due to 
the lack of a gold standard for asthma diagnosis. Asthma can be defi ned 
based on either symptoms or lung function measurements, or both. Several 
questionnaires have been developed since the launching of the fi rst widely used 
respiratory questionnaire in 1960 by the Medical Research Council (MRC) 
of Great Britain. Th ese other questionnaires include the ECSC (European 
Community for Coal and Steel, Brille 1962), the IUATLD (International 
Union against Tuberculosis and Lung Disease, Burney et al. 1989), the Tucson 
Study questionnaire (Lebowitz 1975), the ECRHS (European Community 
Respiratory Health Survey, Burney et al. 1994), Th e OLIN (Lundbäck et al. 
1991), the Tuohilampi questionnaire (Kilpeläinen et al. 2001) and the FinEsS 
questionnaire used in this study.
When validated with regard to a clinical diagnosis of asthma, the question 
about physician-diagnosed asthma yields a high specifi city (Tóren et al. 1993). 
Th e mean sensitivity is lower, 68%, with a range of 48–100% (Tóren et al. 
1993). Sensitivity depends on many things, e.g. accessibility to medical services 
and diagnostic practices. Bronchial hyperresponsiveness (BHR) yields a high 
specifi city (generally over 80%), but a low sensitivity (generally below 50%) for 
asthma in epidemiological studies (Peat et al. 2001). Similar results would be 
expected for a positive bronchodilatation test in spirometry. In other words, 
lung function measurements are oft en normal in asthma patients with proper 
medication, while obstructive lung function or mild BHR without symptoms 
does not necessarily mean asthma. Questions on symptoms related to asthma 
and diagnosis of asthma take into account that asthma is a disease with variable 
symptoms and lung function measures over time. Measurement of sensitization 
to relevant allergens is essential in risk factor assessment for asthma (Peat et al. 
2000). Probably the best way of measuring asthma in epidemiological studies 
would be a combination of questions about symptoms and diagnoses with peak 
expiratory fl ow (PEF) measurements, spirometry, BHR assessment, and skin-
prick tests along with a physician`s conclusion on the data, but this would be 
very expensive in large studies. When the purpose is to study diff erences in 
asthma prevalence, questions on asthma-related symptoms have been shown 
to yield a better combination of sensitivity and specifi city than BHR alone or 
combined with symptoms data (Pekkanen and Pearce 1999).
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2.1.2 Diagnosing asthma in clinical work
Numerous guidelines on asthma diagnosis and treatment exist worldwide, 
the most famous being the GINA guidelines (Global Initiative for Asthma). A 
Nordic consensus report on asthma management was published in 2000 (Dahl 
and Bjermer 2000). Th is report stresses the importance of early detection of 
asthma. PEF measurements and spirometry with a reversibility test for those 
with suspected obstruction are recommended. A positive reversibility test 
is defi ned as an improvement of >15% of PEF (or > 60 l/min) or >12% (or 
>200ml) of FEV1 (forced expiratory volume in one second). Further, a diurnal 
PEF variability [(highest PEF–lowest PEF) x 100/highest PEF)] of at least 15% 
during 2 or more out of 7 days is recommended to indicate asthma.
In the Finnish national asthma guidelines, however, the diagnostic 
requirements used to be more strict: an improvement of ≥15% of FEV1 or 
PEF in reversibility test, or a diurnal PEF variation of ≥20% [(highest PEF–
lowest PEF) x 100/mean of the highest and lowest PEF] was required. Th e 
reversibility criteria for FEV1 changed into ≥12% in March 2006 (Haahtela 
et al. 2006). Th e Estonian diagnostic practices were infl uenced by the former 
Soviet Union criteria until the end of the 1980s. Asthma was defi ned as an 
allergic disease due to atopy or “infection allergy”. Other types of variable 
bronchial obstruction resulted in diff erent diagnoses (Meren et al. 2001). 
Further, asthma patients were not allowed to travel abroad, which might 
have infl uenced diagnostic practices (Meren et al. 2001).
In clinical work, the diagnosis of asthma consists of many components: 
assessment of symptoms and risk factors, clinical examination, lung function 
measurements, assessment of eosinophilic infl ammation and allergy, and 
x-rays to exclude other diseases. Th us, the diagnosis is a summary of many 
components. It is sometimes diffi  cult to discriminate between asthma and 
chronic obstructive pulmonary disease, and the two conditions can co-exist. 
Th e lack of any gold standard for diagnosing asthma and the complexity 
of making the diagnosis have led to diff erent diagnostic practices. Th e 
national reimbursement criteria for asthma medication may also infl uence 
the diagnosis. Th e strict reimbursement criteria for COPD have resulted in 
many Finnish COPD patients with asthma-like reversibility in lung function 
measurements receiving an asthma diagnosis to assure higher reimbursement 
for inhalant medication. Th e large number of asthmatics has led to the 
recommendation that general practitioners set the diagnosis of asthma in 
health care centres in Finland instead of referring the patients to pulmonary 
specialists. Th e diagnostic tools in health care centres are diff erent from 
those in outpatient clinics of hospitals, which use new diagnostic methods, 
enabling early diagnosis of asthma-like infl ammation, further increasing 
diff erences in diagnostic practices. However, in most cases, the diagnosis of 
asthma can easily be made at health care centres. Furthermore, heightened 
awareness of asthma may have increased the activity of diagnosing asthma, 
thus infl uencing the fi gures of asthma prevalence and incidence over time 
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(Lundbäck et al. 2001). In recent years, however, reports of the prevalence 
of asthma reaching a peak have appeared aft er decades of an increasing 
trend (Flemming et al. 2000, Toelle et al. 2004, von Hertzen et al. 2005). 
In a study on schoolchildren in the British Isles, asthma-related symptoms 
and rhinoconjunctivitis decreased from 1995 to 2002, but the prevalence of 
asthma increased, which was explained by diagnosing increasingly milder 
disease (Anderson et al. 2004).
2.1.3 Asthma in Sweden
Th e prevalence of asthma in a Swedish population aged 16–64 years was only 
2.0% in the 1960s (Julin and Wilhelmsen 1967). Asthma was associated with 
female gender, allergic disposition and family history of allergic diseases. 
At the beginning of the 1970s asthma was found in 2.6% of the Swedish 
adult population (Kiviloog et al. 1974). From 1971 to 1981, the prevalence 
of asthma increased among Swedish conscripts from 1.9% to 2.8% (Åberg 
1989). In the ECRHS in 1990–1991, the prevalence of asthma in young adults 
aged 20–44 years had increased up to 5.5–6.8% (Björnsson et al. 1994). A 
similar prevalence, 5.5%, was shown for adults aged 20–69 years in a postal 
survey in southern Sweden in 1992 (Montnémery et al. 2001). Recently, a 
prevalence estimate of 6.5% was published (Masoli et al. 2004).
Th e OLIN studies (Obstructive Lung disease in Northern Sweden) consist 
of well-conducted longitudinal studies of obstructive airway diseases and 
allergic sensitization among children and adults starting in1985. Th e OLIN 
studies showed an asthma prevalence of 5–6% among adults in 1986, an 
increase to 7–8% in 1992 and a further increase to nearly 10% in 1996 
(Lundbäck 1991, 1993, 1998). Th e incidence of physician-diagnosed asthma 
in the OLIN studies was 4–5/1000/year (Rönmark et al. 1997), and when 
corrected for symptomatic subjects at baseline 2.3/1000/year (Lundbäck 
et al. 2001), with a remission of 6% in a ten-year period (Rönmark et al. 
1999a). Th e Nordic part of the ECRHS found an incidence rate of similar 
magnitude in Sweden (Torén et al. 2004).
2.1.4 Asthma in Estonia
Epidemiological data on obstructive airway diseases from Estonia are scarce. 
Low asthma prevalences of 0.5% in Tallinn and 0.4% in Saaremaa were 
described in 1990 (Jannus-Pruljan and Loit 1994). A higher prevalence 
of asthma, 2.0%, was reported from Tartu in the ECRHS (ECHRS 1996). 
Recently, a prevalence rate of 5.4% for clinical asthma in Estonia was 
estimated (Masoli et al. 2004).
Th e FinEsS study has revealed a 2.0% prevalence of physician-diagnosed 
asthma and 2.7% of ever asthma in an Estonian population aged 15–64 years 
in 1996 (Meren et al. 2001). When clinical methods are used that combine 
common symptoms in asthma and BHR, the prevalence of asthma among 
adults in Estonia seems to be at least 5–8% (Meren et al. 2005).
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2.1.5 Asthma in Finland
Th e prevalence of asthma in the 1970s was lower in Finland than in Sweden 
(1.4% vs. 2.6%) (Alanko 1970, Kiviloog et al. 1974). In the Finnish Twin Cohort 
study, physician-diagnosed asthma reported in a postal questionnaire was 
1.35% in 1975 and 1.80% in 1981 (Vesterinen et al. 1988). In 1980, also based 
on a postal questionnaire, the prevalence of asthma was 4.1% in an urban 
population and 2.7% in a rural population (Heinonen et al. 1987). Haahtela 
et al. (1990) reported a steady prevalence of asthma, between 0.02% and 
0.08%, from 1926 to 1961 based on statistics of the defence forces on Finnish 
conscripts, but a linear increase from the 1960s to the end of the 1980s. Th e 
rise was 20-fold from 1961 to 1989, reaching a prevalence of 1.79% in 1989. A 
further increase, with no signs of levelling off , was reported recently (3.45% in 
2003) (Latvala et al. 2005). From 1986 to 1993, an increase in annual incidence 
of persistent asthma was shown for subjects aged 15–64 years based on register 
data (Reijula et al. 1996). Th e fastest increase was demonstrated among subjects 
with an age of less than 30 years. Women showed a rising trend in all age 
groups, while no increase was seen among men over 50 years of age. In the same 
time period, new cases of occupational asthma increased among both women 
and men. However, no signifi cant rise in asthma prevalence was detected from 
1975 to 1990 in the Finnish Twin cohort study (Huovinen et al. 1999). At the 
beginning of the 1990s, asthma in the elderly was assessed in a cross-sectional 
study, demonstrating current asthma in 2.9% of men and 3.8% of women aged 
more than 63 years (Isoaho et al. 1994). In 1996, a postal questionnaire survey 
performed in southern Finland showed a non-response-adjusted prevalence 
of asthma of 4.4% among adults aged 18–65 (Hedman et al. 1999). A lifetime 
occurrence of physician-diagnosed asthma was 4.6% among 10 667 fi rst-year 
university students (Kilpeläinen et al. 2000). Th e highest prevalence estimate 
ever for asthma in the Finnish population, 8.0%, was recently published based 
on available data from diff erent sources (Masoli et al. 2004).
Th e FinEsS study from northern Finland revealed a prevalence of physician-
diagnosed asthma of 6.0% in adults aged 20–69, and a higher prevalence rate 
for ever-asthma, 6.4% (Kotaniemi et al. 2001).
2.1.6 Factors associated with asthma 
Family history, atopy, smoking and obesity
Heredity and atopy have been considered to be main risk factors for asthma, 
as shown in the ECRHS as well as in other studies (Sunyer et al. 1997). In 
a Finnish study on university students, parental asthma or atopy was the 
strongest risk factor for asthma and allergic rhinoconjunctivitis (Kilpeläinen 
et al. 2000). However, in a Finnish study on elderly subjects aged at least 64 
years, current asthma among women was associated with a history of having 
smoked at some time, with exposure to dust at work and with low social status 
(Isoaho et al. 1994).
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Atopy is a strong risk factor for asthma (Burrows et al. 1989). Pearce et 
al. (1999) have calculated a population attributable risk of 37% for asthma 
in adults with allergic sensitization. In a study on Spanish centres of ECRHS, 
asthma among young adults was likewise associated with allergic sensitization 
to perennial and seasonal allergens (Sunyer et al. 1997). In the Swedish part 
of ECRHS, however, cats and dogs were the allergens most closely associated 
with asthma (Plaschke et al. 1999). Similarly in northern Sweden, cats and 
dogs were the most important allergens, while sensitization to house dust 
mites and moulds was rare (Rönmark et al. 1998).
In the longitudinal follow-up of the OLIN studies, the following risk 
factors were reported (OR, odds ratio) for incident asthma in adults: family 
history of asthma 5.53 (95% CI 3.50–8.75), being an ex-smoker 2.30 (95% 
CI 1.29–4.11), current smoking 2.17 (95% CI 1.25–3.79) and female gender 
1.78 (95% CI 1.12–2.84) (Lundbäck et al. 2001). Th e OLIN studies have also 
shown an additive eff ect of smoking and having a family history of asthma; 
a family history of asthma without smoking yielded a 4-fold increase in 
asthma, and smoking history alone without a family history of asthma a 2-
fold increase, while together smoking history and having a family asthma 
history increased the risk to nearly 7-fold (Lundbäck 1998). Among non-
smokers, exposure to environmental tobacco smoke outside the home for 
more than 5 hours daily was found to increase the risk for asthma (OR 
1.79, 95% CI 1.02–3.16) in Estonia (Larsson ML et al. 2003). Th e benefi ts of 
smoking cessation on remission of asthma-related symptoms were clearly 
demonstrated in a recent Norwegian study (Eagan et al. 2004), although 
some asthmatics may report worsening of their symptoms (Hillerdahl and 
Rylander 1984). In a study on Finnish university students, tobacco smoke 
exposure during the fi rst 2 years of life was a signifi cant risk factor for asthma 
(Kilpeläinen et al. 2000). A recent study from Finland showed an increased 
risk for developing asthma among smokers and ex-smokers compared 
with non-smokers, and the conclusion was that smoking causes asthma in 
adulthood (Piipari et al. 2004).
Weight loss in obese asthmatics has been shown to reduce airway 
obstruction and PEF variability both short-term (Hakala et al. 2000) and 
long-term (Stenius-Aarniala et al. 2000). Further, better control of asthma 
symptoms and less need of rescue medication were achieved by weight loss 
(Stenius-Aarniala et al. 2000). Overweight, increased waist circumference 
and increased body mass index (BMI) have been associated with an elevated 
risk of developing asthma (Ford et al. 2004, Kronander et al. 2004). Increased 
BMI as a risk factor for incident asthma occurs in both men and women, 
as well as among both allergic and non-allergic subjects (Rönmark et al. 
2005). Obesity is associated with reduced lung volumes in both genders and 
subsequent airway narrowing, which is greater in men (King et al. 2005).
2 Background18
Occupational exposure
Register data on adult-onset persistent asthma covering the entire employed 
population aged 25–59 years in Finland showed that the age-adjusted 
attributable fraction of occupation was 29% (95% CI 25–33%) for men and 
17% (95% CI 15–19%) for women, indicating an increased risk, especially 
in agricultural, manufacturing and service work (Karjalainen et al. 2001). 
Similarly, in a Swedish study, exposure to welding fumes, man-made mineral 
fi bres, solvents and textile dust were associated with an increased risk for 
asthma, with an attributable fraction of 11% adjusted for gender, smoking 
and age (Torén et al. 1999). Occupational airborne exposures to quartz, metal 
gases, aluminium production and processing, and welding were signifi cantly 
associated with asthma and chronic obstructive airway disease in a study 
from Norway (Bakke et al. 1991).
Occupational risks were assessed in the ECRHS in a large sample of 
15 637 subjects from 12 countries, and the highest risks for asthma were 
found for farmers (OR 2.62 [95% CI 1.29–5.35]), painters (2.34 [1.04–5.28]), 
plastic workers (2.20 [0.59–8.29]), cleaners (1.97 [1.33–2.92]), spray painters 
(1.96[0.72–5.34]) and agricultural workers (1.79 [1.02–3.16]) (Kogevinaas 
1999). Th e proportion of asthma among young adults that was attributed 
to occupation was 5–10%. In a recent study from Norway, the attributable 
fraction of exposure to dust or fumes was 14.4% for the 11-year incidence of 
asthma in a population-based study of adults aft er adjusting for gender, age, 
educational level and smoking (Eagan et al. 2002). Dust or fume exposure 
combined with smoking yielded an attributable fraction of 26.2%.
Socio-economic conditions
In Scotland, low socio-economic status doubled the risk for adult-onset 
wheeze, with other risk factors being current smoking, atopy and having a 
family history of atopy (Bodner et al. 1998). In the OLIN studies, incident 
asthma was associated with manual workers and assistant non-manual 
employees, and a signifi cant association was found between incident 
asthma and being a manual worker in industry (Lundbäck et al. 2001). 
However, Montnémery et al. (2001) could not show any association between 
socio-economic condition and asthma in southern Sweden. No signifi cant 
association of educational level with asthma was found in Norway during the 
1980s (Bakke et al. 1995), but an association between low socio-economic 
status and increased incidence of asthma was recently demonstrated in a 
follow-up of the Hordaland County Cohort study in western Norway (Eagan 
et al. 2004). Th e steepest increase in asthma prevalence was noticed among 
those conscripts with a low socio-economic status in Sweden (Bråbäck et 
al. 2005). A 6-fold prevalence of asthma compared with the national rate 
was found among homeless children in New York (McLean et al. 2004), and 




Large diff erences in prevalence of asthma and allergic sensitization among 
children have been documented between former West and East Germany (von 
Mutius et al. 1992, 1994). Th e fi rst of these two papers reported a higher lifetime 
prevalence of bronchitis in East Germany, but no diff erence in prevalence 
of asthma. Th e latter reported a higher prevalence of asthma in the West 
compared with the East based on BHR in cold air challenge and questionnaire 
data. However, signifi cantly higher prevalences for wheeze and coughing were 
found among children living in East Germany. Further, a higher prevalence 
of allergic sensitization to house dust mites, grass, birch, hazel, cats and dogs 
was found in the West. An explanation for the bronchitic symptoms in the 
East was sought from high levels of diff erent pollutants (von Mutius et al. 
1995). In a study with similar methods on another sample of schoolchildren, 
an increased prevalence of hay fever and allergic sensitization in the former 
East Germany was reported in 1998, but no change was observed in prevalence 
of asthma, asthma-related symptoms or BHR (von Mutius et al. 1998). Since 
then, diff erences in early childhood environment have been explored, and 
attention has been directed to living on a farm in early childhood, which has 
been found to prevent the development of allergic sensitization and asthma in 
many studies (Braun-Fahrländer et al. 1999, von Ehrenstein et al. 2000, Ernst 
and Cormier 2000, Kilpeläinen et al. 2000, Riedler et al. 2000). In the ECRHS 
pooled data on Belgium, France, Netherlands, Sweden and New Zealand, living 
on a farm during childhood did not protect against asthma in adulthood, but 
did protect against allergic sensitization (Leynaert et al. 2001). Interestingly, 
the farm environment was associated with a higher prevalence of allergic 
rhinitis and asthma among children in New Zealand (Wickens et al. 2002). 
In the ECRHS data from Belgium, asthma, asthma symptoms and house dust 
mite allergy were shown to be more frequent in urban Antwerp than suburban 
Antwerp (Wieringa et al. 1997). Diff erences as large as between former East 
and West Germany were demonstrated, but the reasons remained unidentifi ed. 
Th e rural environment was also associated with a lower prevalence of asthma 
and allergic sensitization among children in Kenya (Perzanowski et al. 2002), 
as well as among adults in Mongolia (Viinanen 2004).
In a study from Norway, exposure to fungi and endotoxins was associated 
with a lower risk for atopic asthma, but a higher risk for non-atopic asthma 
in farmers (Eduard et al. 2004). Endotoxin levels in dust samples from the 
mattress were inversely related to occurrence of hay fever, atopic asthma 
and atopic sensitization in schoolchildren (Braun-Fahrländer et al. 2002). 
Endotoxin is a lipopolysaccharide of the Gram-negative bacterial wall. Past or 
present pet ownership has also been shown to reduce the risk of development 
of asthma in pre-teenage children (Rönmark et al. 1998, Perzanowski et al. 
2002). House dampness and mould growth have been linked to an increased 
risk of asthma in both children (Åberg et al. 1996, Nafstad et al. 1998) and 
adults (Zock et al. 2002).
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2.1.7 Control of asthma
How are diff erent guidelines for asthma applied in real life? In a study of 
asthmatics referred to a US university hospital emergency department for 
treatment, 60% of asthmatics were under-treated with respect to medication 
recommended by the guidelines and nearly 90% had no written instructions 
in case asthma worsened (Taylor et al. 1999). Asthma knowledge was 
poor, and only 60% of patients were seen by a physician yearly to control 
asthma. Th e AIRE (Asthma Insights and Reality in Europe) survey showed 
suboptimal asthma control in seven European countries with Sweden among 
these (Vermeire et al. 2002). Th is study revealed an insuffi  cient monitoring 
of asthma. Less than half of adults had a written asthma management plan. 
Th e use of inhaled corticosteroids was not according to the guidelines in 
any of the countries. Of the adults, 15–25% had severe persistent asthma 
symptoms and 20–28% moderate persistent symptoms. In a French study, 
85% of patients with severe asthma in Paris and 60% in Montpellier did not 
receive anti-infl ammatory treatment (Bousquet et al. 1996). Th e national 
Asthma Programme in Finland showed improved treatment of asthma 
patients, with reduced hospital days and mortality due to asthma, during 
the 10-year programme that was initiated in 1994 (Haahtela et al. 2001).
2.2 Allergic sensitization in adults
Allergic sensitization has been a growing burden in Western countries 
(von Mutius et al. 1998, Linneberg et al. 2000). An increase in prevalence 
of atopic diseases, as well as a shift  towards stronger sensitization, has been 
shown among children in Eastern Germany (Heinrich et al. 2002). Recent 
data on specifi c IgE for trees, grass and cats of middle-aged men showed 
that the proportion of those with specifi c IgE was signifi cantly lower in 
earlier born cohorts (Law et al. 2005). While the precise reason for this rise 
in allergic sensitization remains unknown, the leading theory since the 
1980s has been the hygiene hypothesis (Strachan 1989, Braun-Fahrländer 
et al. 1999, von Hertzen and Haahtela 2004). However, some challenges to 
the hygiene hypothesis exist, e.g. the very high prevalence of allergy and 
asthma among children living in very poor conditions in inner cities of 
North America (McLean et al. 2004). Diff erent immunoresponse profi les 
have been demonstrated depending on the exposure to diff erent allergens 
such as house dust mites and cats (Platts-Mills et al. 2001).
2.2.1 Defi nitions
Th e EAACI (European Academy of Allergy and Clinical Immunology) 
position paper gives the following defi nition for atopy: “Atopy is a personal 
or familial tendency to produce IgE antibodies in response to low doses of 
allergens, usually proteins, and to develop typical symptoms such as asthma, 
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rhinoconjunctivitis, or eczema/dermatitis” (Johansson et al. 2001). Th e term 
atopy is recommended to describe a tendency or trait, but not a disease. 
Allergy is defi ned as follows: “Allergy is a hypersensitivity reaction initiated 
by immunologic mechanisms”. A positive skin-prick test should be referred to 
as “skin-prick test-positive”. We have followed these recommendations, but 
also refer to positive responses in skin-prick tests as allergic sensitization.
2.2.2 Sweden and Estonia
As part of the ECRHS, atopy was studied by measuring IgE antibodies against 
Dermatophagoides pteronyssinus, birch, timothy, cats, and Cladosporium in 
young adults of Uppsala, Sweden, and Tartu, Estonia (Jõgi et al. 1998). Th e 
prevalence of IgE sensitization was lower in Tartu (19.1%) than in Uppsala 
(32.3%). Sensitization to birch, timothy, cats and Cladosporium was more 
common in Uppsala, while sensitization to mites occurred more frequently 
in Tartu.
Th e fi rst FinEsS report on allergic sensitization described data from 
Tallinn, where sensitization was surprisingly common, with a prevalence 
of 34.5% among subjects aged 17–66 years, and 39.3% among those aged 
20–44 years (Raukas-Kivioja et al. 2003). Th e prevailing allergen was the 
cockroach, followed by the mugwort, dog and two storage mites. Th is 
cockroach sensitization could be in part a cross-sensitization to dust mites 
and storage mites.
2.2.3 Finland
In 1978, a study comprising adolescents and conscripts from southeastern 
Finland showed single prick test-positive reactions in nearly half of subjects 
(Haahtela 1980).
Kilpeläinen et al. (2001) examined university students aged 18–25 years 
that consisted of altogether 150 students with a history of wheezing or 
asthma and 140 students without asthmatic symptoms. At least one prick 
test positivity was found in 68.7% of those with asthma symptoms and in 
42.1% of those without symptoms. Th e high proportions may be due to the 
large allergen panel used as well as to the selection procedures.
A cross-sectional study on a random population sample of subjects aged 
25–54 years was performed in eastern Finland; 34.2% of subjects had at 
least one positive prick test reaction to airborne allergens (Vartiainen et 
al. 2002).
2.2.4 Factors associated with allergic sensitization
Family history of atopy is a well-known risk factor for allergic sensitization. 
Other risk factors include many environmental conditions such as exposure 
to furred animals during childhood, type of living environment, dampness 
problems at home and domestic crowding. Th e role of breastfeeding has 
been controversial.
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Urban living has been shown to increase the risk for allergic sensitization 
(Bråbäck et al. 1994). Th e cause for the urban-rural diff erence was initially 
thought to be pollution, but the prevalence of atopy was demonstrated to 
be higher in less polluted areas (Bråbäck et al. 1994, von Mutius et al. 1994, 
Nicolai et al. 1997). Th e focus was then turned to the farm environment and 
to pet ownership. Living on a farm during childhood was shown to protect 
against allergic sensitization in adulthood (Svanes et al. 1999, Kilpeläinen et 
al. 2000, Leynaert et al. 2001). Living in a community with more than 100 000 
inhabitants was a risk factor for allergic sensitization in Germany (Nicolai 
et al. 1997). In Japan, allergic rhinoconjunctivitis due to Japanese cedar 
was more common among subjects living near inter-city roads than among 
those living in the city or in farming areas and in the mountains, which 
was explained by eff ects of air pollution and car exhaust fumes (Ishizaki T 
et al. 1987).
Cat ownership was inversely related to allergic sensitization to animals 
in Estonia, Poland and Sweden in subjects aged 10–12 years (Bråbäck et 
al. 1995). Having pets at home during childhood was also shown to be a 
protective factor for allergic sensitization (Roost et al. 1999). Further, a dose-
response relationship was discovered: exposure to more than two cats or dogs 
in early life reduced the risk of allergic sensitization at the age of 6–7 years 
(Ownby et al. 2002), and persistent exposure during childhood yielded the 
most pronounced reduction in early teenage years (Rönmark et al. 2003). 
Allergic sensitization was inversely related to the number of older siblings 
in the UK (Strachan et al. 1997). Domestic crowding and larger family size 
decreased the risk of allergic sensitization in children in the Baltic area 
(Bråbäck et al. 1995) and in Latin America (Cooper et al. 2004).
Low socio-economic status protected against atopy in Latin America 
(Cooper et al. 2004), and higher socio-economic status was related to allergic 
sensitization in the UK (Strachan et al. 1997). A higher level of education 
also increased the risk for allergic sensitization in Germany (Nicolai et al. 
1997). Low socio-economic status, by contrast, was a signifi cant risk factor 
for cockroach sensitization in asthmatic children in the US (Sarpong et al. 
1996). Cockroach sensitization together with sensitization to house dust 
mites were shown to be the main risk factors for asthma in inner city children 
in the US (Call et al. 1993).
Exposure to tobacco smoke (ETS) during infancy was a signifi cant risk 
factor for allergic sensitization in Estonia, but not in Sweden or Poland 
(Bråbäck et al. 1995). A prospective study in the fi rst three years of life in 
children with both parents atopic showed ETS exposure to be a risk factor 
for asthma, but it had little or no eff ect on allergic sensitization (Murray 
et al. 2004). Recently, parental smoking during childhood was found to 
be a signifi cant risk factor for allergic sensitization in adults (Larsson ML 
et al. 2005). Serum IgE level is higher in smokers than in non-smokers 
(Zetterström et al. 1981). In rats, exposure to tobacco smoke was shown 
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to increase serum IgE levels and enhance sensitization to ovalbumin 
(Zetterström et al. 1985).
Higher levels of endotoxin exposure at home have been associated with 
decreased risk for allergic sensitization in adults, which may be related to 
a farm environment and pet ownership, as both of these result in higher 
exposure to endotoxins (Gehring et al. 2004). In the last few years, a growing 
body of evidence has emerged that suggests that higher endotoxin exposure 
is protective against allergic sensitization (Gereda et al. 2000, 2001, Braun-
Fahrländer et al. 2002, Gehring et al. 2002). Endotoxin stimulates immunity 
towards non-allergic pathways rather than allergic ones.
Geographical position as well as factors related to climate and housing 
aff ect the profi le of important allergens. In northern Sweden, house dust 
mite and cockroach allergens are generally unmeasurable (Perzanowski et 
al. 1999) and sensitization to dust mites and cockroaches is rare (Rönmark 
et al. 1998, Perzanowski et al. 1999), whereas the cockroach is the major 
allergen in Tallinn, Estonia (Raukas-Kivioja et al. 2003).
WHO (2002) recommendations for prevention of allergy and allergic 
asthma emphasize such measures in primary prevention as avoidance of 
smoking and exposure to environmental tobacco smoke, breast-feeding 
exclusively until 6 months, avoidance of damp housing conditions, reduction 
of indoor pollutants and elimination of sensitizing and highly irritating 
agents in occupational environments.
2.2.5 Multiple sensitization
Th ere is growing interest in quantifying allergic sensitization. Besides 
assessing specifi c allergens to which a person is sensitized, quantifying 
the level of allergic sensitization to IgE-mediated specifi c allergens and to 
allergens overall would be useful. Th is can be done by summarizing the 
responses to positive prick test reactions or by summarizing specifi c IgE 
values.
In children, the prevalence rates of asthma and hay fever have been 
shown to increase with an increasing number of positive prick test responses 
(Sears et al. 1993). Th e probability of allergic disease rises with an increasing 
sum of allergen-specifi c IgE levels or an increasing number of positive IgE 
responses (Wickman 2004).
2.3 Epidemiology and diagnosis of chronic bronchitis
2.3.1 Diagnosing chronic bronchitis
Th e diagnosis of chronic bronchitis is based on symptoms and patient 
history. Chronic bronchitis is defi ned as the presence of cough and sputum 
production on most days for at least 3 months in two consecutive years when 
other causes have been excluded. Th is defi nition dates back to the 1950s and 
2 Background24
it was approved by WHO (Ciba Guest Symposium 1959). In patients with 
these symptoms the disease may progress to chronic obstructive pulmonary 
disease (COPD), which can be diagnosed when airway obstruction is 
demonstrated. Th e GOLD (Global Initiative for Chronic obstructive Lung 
Disease) guidelines refer to chronic bronchitis without obstruction as stage 
0; i.e. at risk for COPD. Th e GOLD criteria defi ne COPD as FEV1/FVC<0.7. 
Subjects with chronic bronchitis or COPD may also have emphysema, which 
is a pathological term meaning permanent enlargement of the distal airways. 
Early diagnosis of chronic bronchitis is important to prevent progression 
to COPD (Lindberg et al. 2005). Further, chronic bronchitis was associated 
with increased mortality among the elderly in the Copenhagen City Heart 
Study (Lange et al. 2003).
2.3.2 Chronic bronchitis in Sweden
In the mid-1960s, the prevalence of chronic bronchitis was 2.1% among 
men and 1.8% among women aged 16–64 years in southern Sweden (Julin 
and Wilhelmsen 1967). In that study, 46% of men and 27% of women were 
smokers, but 90–91% of those with chronic bronchitis smoked. In the OLIN 
studies, an estimated prevalence of 9% was established, and a considerable 
under-reporting of symptoms was revealed among middle-aged and elderly 
smokers (Lundbäck et al. 1993). Further reports from the OLIN studies 
suggested an underdiagnosis of COPD since only one-third of the subjects 
fulfi lling the BTS (British Th oracic Society) criteria for COPD (FEV1/
VC<0.7 and FEV1<80%) had been diagnosed as having chronic bronchitis, 
emphysema or COPD (Lundbäck et al. 2003b). In a report from the FinEsS 
studies, chronic productive cough was reported by 7.0% in Norrbotten, 
northern Sweden, while the prevalence of physician-diagnosed chronic 
bronchitis was 3.8% (Lindström et al. 2001).
2.3.3 Chronic bronchitis in Estonia
In the 1970s, the prevalence of chronic bronchitis among subjects aged 
35–54 years was around 7% in Tallinn and 8% in Saaremaa (Utkin et al. 
1989). Th e same study showed an increasing trend in mortality rates due 
to chronic bronchitis, from 7.7 to 11.0 per 100 000 between 1980 and 1985. 
A recent FinEsS publication revealed a higher prevalence of physician-
diagnosed chronic bronchitis in non-Estonians (mainly Russians), 13.5%, 
than in Estonians, 7.9%, living in Estonia (Jannus-Pruljan et al. 2004). Th is 
diff erence was explained by more extensive smoking habits and exposure 
to ETS in non-Estonians, as well as by socio-economic factors.
2.3.4 Chronic bronchitis in Finland
Th e prevalence of chronic bronchitis has been higher in Finland than in 
Sweden since the 1960s. Prevalence estimates of up to 27.0% among all men 
and 5.5% among all women in the age group 40–64 years were reported in 
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Finland, the corresponding proportions among non-smokers being 5.7% and 
4.5%, respectively (Huhti 1965). In that study, 58.8% of men and 10.2% of 
women were smokers. A prevalence of 8% among Finnish farmers was found 
in the early 1980s (Terho et al. 1987). In a study on elderly Finns, chronic 
productive cough was reported by 12.5% of men and 6.5% of women (Isoaho 
et al. 1994). Furthermore, a considerable rate of underdiagnosis of COPD 
was revealed: a previous diagnosis of COPD had been assigned to 50% of 
men and 40% of women. In a nationally representative sample of subjects 
aged 30 years or over, an age-adjusted prevalence of chronic bronchitis was 
found in 19.3% of men and 6.5% of women, and a prevalence of clinically 
signifi cant airways obstruction in 10.8% and 5.1%, respectively (von Hertzen 
et al. 2000). Half of the bronchitic women had never smoked.
In the FinEsS studies, a chronic productive cough rate of 11% of was 
observed in northern Finland, while only 3.1% reported physician-diagnosed 
chronic bronchitis (Lindström et al. 2001). Recently, an overall prevalence 
of COPD by BTS criteria was 5.4% and by GOLD criteria 9.4% in northern 
Finland (Kotaniemi et al. 2005).
2.3.5 Factors associated with chronic bronchitis and chronic 
obstructive pulmonary disease
Smoking
Smoking is the principal risk factor for chronic bronchitis and COPD 
(Siafakas et al. 1995, Lundbäck et al. 2003b, Mannino et al. 2003). It was 
previously held that 15–20% of smokers develop COPD, but the OLIN 
studies revealed that up to 50% of elderly smokers may develop COPD 
(Lundbäck et al. 2003b). Screening of smokers aged 40–55 years uncovered 
a high prevalence of COPD, 27%, in Sweden (Stratelis et al. 2004).
Other risk factors
Other risk factors include alpha-1-antitrypsin defi ciency, genetic factors, 
occupational exposures, low socio-economic status and possibly dietary or 
childhood environmental factors (Antó et al. 2001). In China, the incidence 
of COPD decreased aft er household coal stoves were improved (Chapman 
et al. 2005). Th e Copenhagen City Heart Study revealed a considerable 
diff erence in FEV1 between the lowest and highest socio-economic group 
adjusted for smoking (Prescott et al. 1999). Th is diff erence was 400 ml for men 
and 259 ml for women. Further, those in the lowest socio-economic group 
had a threefold risk for hospital admission for COPD. Low socio-economic 
position was associated with an increased risk for chronic bronchitis in 
Sweden (Montnémery et al. 2001). A French study, by contrast, showed 
no diff erence in chronic bronchitis occurrence between socio-economic 
classes; however, classifi cation to only three socio-economic classes was 
used, which may have yielded an insensitive rating (Huchon et al. 2002). 
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Occupational exposures have been recognized as a risk factor for COPD 
(Becklage 1989, Bakke et al. 1991). Th e attributable fraction of occupation 
on the development of COPD was 11% overall and more than 50% among 
non-smokers in a recent Swedish study on construction workers (Bergdahl 
et al. 2004). Low education level has also been associated with an increased 
risk for chronic bronchitis-related symptoms and obstructive lung disease 
(Bakke et al. 1995, Eagan et al. 2004). Th e FinEsS comparison of northern 
Sweden and northern Finland showed an additive eff ect of smoking and 
having a family history of obstructive airway disease on the risk for chronic 
bronchitis (Lindström et al. 2001).
2.3.6 Burden of chronic bronchitis and chronic obstructive 
pulmonary disease
According to the WHO, COPD is expected to be the third most common 
cause of death worldwide by 2020. Prevalence of COPD is 4–10% in most 
studies, and it is expected to increase in the future (Halbert et al. 2003, 
Lundbäck et al. 2003a). Comparison of prevalence rates internationally is 
diffi  cult because diff erent diagnostic criteria have been used (Halbert et al. 
2003).
Already in 1997, the total costs of chronic bronchitis and COPD were 
estimated to be more than 800 million euros in Finland, and a rise in costs 
was anticipated (Laitinen and Koskela 1999). National Finnish guidelines 
of chronic bronchitis and COPD stress early detection and active treatment 
(Laitinen and Koskela 1999). Early detection is essential because of the 
irreversibility of the disease and the steeply rising costs with its progression. 
Further, the response to medication is limited in COPD. Th e most important 
treatment of chronic bronchitis and COPD is smoking cessation, which 
has been shown to relieve symptoms and to halt excessive lung function 
decline (Willemse et al. 2004). Public campaigns on the harms of smoking 
and measures to reduce exposure to tobacco smoke are valuable preventive 
means.
2.4 Respiratory symptoms in the general population 
Respiratory symptoms are markers of lung disease, and assessment 
of symptoms is an essential part of diagnostics and follow-up. Further, 
respiratory symptoms in the elderly are strong predictor of mortality (Hewitt 
et al. 2005).
Th e prevalence of respiratory symptoms in the ECRHS varied substantially 
between countries and even within a country (ECRHS 1996). Highest 
prevalence estimates of symptoms were generally found in English-speaking 
countries, including the UK, US, New Zealand and Australia. Th e prevalence 
of wheezing ranged from 19.8% to 23.2% in Sweden, while the prevalence 
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in Tartu, Estonia, (26.8%) ranked among the highest (ECRHS 1996). Th e 
same question on wheezing was used in the FinEsS questionnaire, yielding 
prevalence estimates of 18.6% in northern Sweden, 18.9% in northern 
Finland and 21.7% in Estonia (Lindström et al. 2001, Meren et al. 2001).
Th e most common respiratory symptom in the diff erent FinEsS centres 
was sputum production, with 19.1% reporting this in northern Sweden, 
25.0% in northern Finland and 29.5% in Estonia (Lindström et al. 2001, 
Meren et al. 2001). Long-standing cough was another common symptom; 
in the FinEsS study, it was reported by 24.0% of subjects in Estonia and by 
16.7% in northern Finland (Kotaniemi et al. 2001, Meren et al. 2001). In 
the OLIN studies, the prevalence of long-standing cough was lower, around 
10%, while sputum production at 22% was similar to in the FinEsS studies 
(Lundbäck et al. 1991).
2.5 Reasons for conducting epidemiological studies
Peat et al. (2001) have summarized the goals and benefi ts of epidemiological 
studies as follows:
- To measure prevalence and to quantify the burden of illness
- To identify etiological factors and understand mechanisms in order to 
develop better preventive and treatment strategies
- To identify “at risk” groups in order to administer preventive 
pharmacological or environmental strategies effi  ciently
- To evaluate responses to new treatments or interventions 
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3 Aims of the study
1. To assess prevalence and risk factors for respiratory symptoms, asthma 
and chronic bronchitis in Helsinki
2. To compare prevalence of respiratory symptoms, asthma and chronic 
bronchitis between Helsinki, Stockholm and Tallinn
3. To compare risk factors, including socio-economic status, for respiratory 
conditions between Finland, Sweden and Estonia 
4. To compare diagnostic practices of asthma and chronic bronchitis 
between Finland, Sweden and Estonia
5. To evaluate the prevalence and determinants of allergic sensitization in 
Helsinki
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4 Materials and methods
4.1 Study areas
Th e FinEsS study was performed in altogether eight areas in three countries. 
Th e study centres in Finland were Helsinki and the southwestern and central 
parts of Lapland, including Kemi, Kemijärvi, Tornio and Rovaniemi. In 
Estonia, Tallinn, Saaremaa and Narva participated. In Sweden, the study 
areas were Stockholm, Örebro and the province of Norrbotten (Figure 1).
Studies I and V report results for Helsinki. Study II is a comparison 
between Helsinki, Stockholm and Tallinn for subjects aged 20–64 years. 
Studies III and IV are based on the pooled data of all centres for subjects 
aged 20–64 years.
Figure 1. Map of the study areas.
4.2 Study design
Th e fi rst part of the FinEsS study consisted of a postal questionnaire, which 
was distributed in 1995–1996. Th e same questionnaire in each subject`s 
native language, i.e. in Swedish, Finnish, Estonian or Russian, was used 
(Appendix 1).
Th e second part of the FinEsS study consisted of a structured interview 
and clinical examinations. All subjects underwent a structured interview 
and spirometry. Skin-prick tests were performed on subjects under 61 years 
of age. A bronchial provocation test with histamine was performed and 
exhaled nitric oxide (NO) was conducted on half of the subjects, and lung 
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sounds were recorded in one-fourth. Th is thesis presents the results of the 
prick tests; results of the diff erent lung function measurements are not 
reported here.
4.3 Study population
Th e study population consisted of randomly selected subjects obtained 
from population registers (Väestörekisterikeskus in Finland, Estonian State 
Computing Centre in Estonia, Swedish Population Register in Sweden) and 
designed to correspond to the general population with respect to age and 
gender. Th e study populations in Finland and Sweden comprised of subjects 
aged 20–69 years, and in Estonia 15–64 years.
In Helsinki, 8000 subjects were originally randomized for the study, 
but 10 subsequently moved away from Helsinki and were excluded. Of the 
7990 invited, 4 were deceased, 3 did not answer personally, and a further 
119 had moved away from Helsinki. A total of 6062 (76%) participated in 
the fi rst part of the study. Of those who responded, a randomly selected 
sample of 1200 subjects was invited to the second part of the study; 643 
(54%) participated. Of these, 503 were under 61 years of age and eligible 
for prick tests. Prick tests were not performed on fi ve subjects: two were 
pregnant and three used regular antihistamine treatment. Th us, 498 prick 
tests were carried out. Aft er exclusion of those showing no response to the 
positive control (4 subjects) and those reacting to the negative control (29 
subjects), 465 valid prick tests remained for analysis.
Figure 2. Study population in Helsinki.
8000 study subjects
10 moved away
7990 invited to part I
6062 responders
2600 men/3462 women
5671 aged 20–64 years
comparisons between centres
1200 invited to part II
643 participated




Th e study populations used in comparisons between the countries are shown 
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in Table 1. Study II compares the data of Helsinki, Stockholm and Tallinn 
for the age group of 20–64 years. Studies III and IV have pooled the data of 
all centres for this age group, thus including information for 44 483 (76%) 
participants out of the 58 661 invited.
Table 1. Study populations in comparisons between centers.
  Age group 20–64 years  
  Male Female Total
Sweden Stockholm 3721 3732 7453
participants 2484 2851 5335 72%
Norrbotten 4025 3628 7653
participants 3349 3162 6511 85%
Örebro 3349 3360 6709
participants 2660 2823 5483 82%
Finland Helsinki 3564 3964 7528
participants 2429 3242 5671 75%
Lapland 3781 3603 7384
participants 2971 3126 6097 83%
Estonia Tallinn 5170 6146 11 316
participants 3099 4320 7419 66%
Narva 2511 2949 5460
participants 1670 2145 3815 70%
Saaremaa 2608 2550 5158
participants 1975 2177 4152 80%
4.4 Methods
4.4.1 Questionnaires
Th e postal questionnaire contained 20 questions. It was developed from 
the OLIN studies questionnaire (Lundbäck et al. 1991, 1993), which in turn 
was based on a revised version of the British Medical Research Council 
questionnaire (MRC 1960). Th e questionnaire included modifi cations from 
the ATS (American Th oracic Society) (Ferris 1978) and Tucson (Lebowitz 
et al. 1975) questionnaires, also containing questions from the IUATLD 
(International Union Against Tuberculosis and Lung Disease) (Burney et 
al. 1989). Two reminders were sent for those who did not respond to earlier 
letters.
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Th e screening question for asthma, questions 10 (any wheezing during 
the last 12 months), 10a (with breathlessness) and 10b (without colds), was 
identical to ECRHS (Burney et al. 1994) questions 1, 1.1 and 1.2. Question 
number 10 (ECHRS 1) was originally in the British Medical Research 
Council`s questionnaire in 1986 and in the IUATLD questionnaire of the 
same year. Th e question on chronic productive cough refers to the largely 
used defi nition of chronic bronchitis, the CIBA defi nition (CIBA Guest 
Symposium 1959). Questions 1–10, 13 and 14 were the same as in the 
OLIN studies. Questions 11, 12 and 17–20 were not included in the OLIN 
questionnaire. Th e FinEsS questionnaire is presented in Finnish and English 
in Appendices 1 and 2.
Th e interview in the second part of FinEsS consisted of 162 questions 
asked by physicians involved in the study. Study V is based on answers to 
this interview questionnaire. Questions about physician-diagnosed asthma, 
long-standing cough and any wheezing were identical to the postal questions 
3, 7 and 10. Th e three additional questions are described in the defi nitions 
section. Th e interview questionnaire was not included in this thesis as an 
appendix because results are mainly based on the postal questionnaire.
4.4.2 Skin-prick tests
Skin-prick tests were performed to 15 common allergens using commercial 
extracts and validated methods. Th e tests were performed according to the 
recommendations in the EAACI position paper, except as single tests on one 
forearm (Dreborg 1989). Th e allergens consisted of cat (10 HEP), dog (10 
HEP), cow (1:100 w/v), horse (10 HEP), birch (10 HEP), timothy (10 HEP), 
mugwort (10 HEP), Alternaria alternata (100 bu/ml), Cladosporium herbarum 
(1:20 w/v), Dermatophagoides pteronyssinus (10 HEP), Dermatophagoides 
farinae (10 HEP), Acarus siro (1:100 w/v), Lepidoglyphus destructor (100 
bu/ml), Blatella germanica (cockroach)(1:100 w/v) and latex (100 IR/ml) 
extracts. Histamine 10 mg/ml was used as a positive control, and the solvent 
(glycerin) as a negative control. All allergen extracts were provided by ALK, 
Denmark, except for latex, which was provided by Stallergenes, France. Aft er 
15 min, the wheal size was measured in millimetres in two perpendicular 
directions starting from the longest diameter, and their mean was recorded 
as the response. A response of at least 3 mm was regarded as positive. Th ose 
who did not react to the positive control and those who reacted to the 
negative control were excluded from the analyses.
4.5 Defi nitions
Asthma and chronic bronchitis were classifi ed in two ways: Th ose who 
answered ”yes” to the question ”Have you been diagnosed as having asthma 
by a doctor?” or ”Have you been diagnosed as having chronic bronchitis 
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or emphysema by a doctor?” were classified as having physician-diagnosed 
asthma or physician-diagnosed chronic bronchitis. Those who answered 
”yes” to ”Have you ever had asthma?” or ”Have you ever had chronic 
bronchitis or emphysema?” were labelled as ever-asthma or ever-chronic 
bronchitis.
Definitions of term used are as follows:
Any wheeze: ”Have you had wheezing or whistling in your chest at any 
time in the last 12 months?”
Wheezing with shortness of breath apart from colds: ”yes” to the question 
about any wheeze, and ”yes” to the following two questions ”Have you 
been at all breathless when the wheezing noise was present?” and ”Have 
you had this wheezing or whistling when you did not have a cold?”
Recurrent wheeze: ”Have you had wheezing, whistling, or a noisy sound 
in your chest when breathing?”
Attacks of shortness of breath: ” Have you now or have you had asthma 
symptoms in the last 12 months (intermittent breathlessness or attacks of 
breathlessness). The symptoms may exist simultaneously with or without 
cough or wheezing.”
Current asthma: Physician-diagnosed asthma and use of asthma medication 
or attacks of either shortness of breath during the previous 12 months or 
wheezing.
Sputum production: ”Do you usually have phlegm when coughing, or do 
you have phlegm which is difficult to bring up?”
Long-standing cough: ”Have you had long-standing cough during the 
last years?”
Chronic productive cough: Sputum production when coughing on most 
days during periods of at least 3 months in 2 successive years.
In Study V, the answers are based on an interview. Definitions of physician-
diagnosed asthma, long-standing cough and any wheeze are the same as 
above. Two new questions were introduced: allergic rhinoconjunctivitis 
and attacks of shortness of breath in the last 12 months, as described 
below:
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Allergic rhinoconjunctivitis: ” Do you have or have you had hay fever or 
allergic rhinitis or conjunctivitis?”
Attacks of shortness of breath in the last 12 months: ” Have you had any 
attacks of breathlessness or attacks of shortness of breath in the last 12 
months?”
Allergic sensitization was defined as at least one positive skin-prick test 
reaction.
Multisensitization refers to at least four positive reactions in the prick 
tests.
4.6 Socio-economic classifi cation
The socio-economic classification used in Studies I and III is based 
on occupation according to the socio-economic classification system 
elaborated by Statistics Sweden (Appendix 3). The classification was 
developed by Statistics Sweden to also be used for research purposes and 
has been used in many studies in Sweden, including the OLIN studies. 
This classification is primarily based on occupation and in its most 
aggregated form consists of six groups formed by merging the 18 basic 
categories of the economically active population: 1) unskilled and semi-
skilled workers, 2) skilled workers, 3) assistant non-manual employees, 
4) intermediate non-manual employees, 5) employed and self-employed 
professionals, higher civil servants and executives, and 6) self-employed 
(other than professionals).
Low socio-economic status and “manual workers” refer to both manual 
workers in industry and manual workers in service (groups 1 and 2). 
In our study, we have combined groups 4 and 5 since no significant 
differences were found between them. Results for housewives, students 
and those with unknown occupation have been presented separately.
4.7 Statistical methods
Chi-square and Fisher´s exact tests were used to analyse differences 
between groups. A p-value of less than 0.05 was considered significant. 
One-way analysis of variance (ANOVA) was used for testing trends when 
analysing differences between age groups or smoking categories. The 
Mantel-Haenszel test was used to calculate prevalence rates standardized 
by age and smoking in study II. Multiple logistic regression analysis was 
applied to calculate odds ratios (ORs) when taking several independent 
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variables into account. Most statistical analyses were performed with 




5.1 Helsinki (Studies I and V)
5.1.1 Respiratory symptoms and smoking 
Th e prevalence of respiratory symptoms was high in the adult population 
in Helsinki (Study I: Figure 1). When analysed in 10-year age groups, the 
highest prevalence fi gures for diff erent symptoms were usually found in the 
elderly (60–69 years) in both genders. Th is was true for long-standing cough, 
sputum production, chronic productive cough and recurrent wheezing. 
Tightness in the chest when waking up and any wheezing were the most 
common in the youngest age group of 20–29 years. Prevalences of chronic 
productive cough and recurrent wheezing were two- or threefold among 
the elderly compared with the youngest age group, while diff erences in 
other symptoms were smaller between age groups. Attacks of shortness of 
breath, tightness in the chest upon awakening and long-standing cough were 
signifi cantly more common among women than men, while the opposite was 
true for any wheezing. No gender diff erence was seen for sputum production 
or chronic productive cough.
Smoking was common among those aged less than 40 years; more than 
40% of men and 34% of women smoked. Of the elderly, 26% of men and 
19% of women were smokers. Respiratory symptoms were signifi cantly 
associated with smoking (Study I: Figures 1–3). “Any wheezing” during 
the last year was reported by 31% of smokers and 13% of non-smokers 
(p<0.001). Prevalence of recurrent wheezing was 12% in smokers and 4% 
in non-smokers (p<0.001). Similarly, shortness of breath during the last 
year was present in 16% of smokers and 10% of non-smokers (p<0.001), 
with the corresponding proportions for long-standing cough being 25% 
and 17% (p<0.001).
5.1.2 Asthma
Th ere were 398 subjects (6.6%) with physician-diagnosed asthma: 145 men 
(5.6%) and 253 women (7.3%) (p=0.007). Ever-asthma was reported by 159 
men and 278 women. Among the elderly (60–69 years), physician-diagnosed 
asthma was reported by 10.6% of men and 12.1% of women, and asthma 
medication was used by 9.5% and 11.2%, respectively. Attacks of shortness of 
breath and wheezing during the last year were reported by 71–84% of those 
with asthma. Men reported signifi cantly more wheezing than women (Table 
2). Table 2 below presents the prevalences of diff erent respiratory symptoms 
in subjects with physician-diagnosed asthma according to smoking habits. 
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Because the smoking status of four asthmatics was unknown, they are not 
included in this table. Clearly, asthmatics who smoke are more symptomatic 
than non-smoking ones, but the use of asthma medication is less frequent 
among them. Assessing the proportion of asthma diagnosis among subjects 
with asthma-related symptoms revealed a greater proportion in women 
than in men; 26.2% of women and 20.4% of men reporting any wheezing 
had physician-diagnosed asthma. Similarly, 16.0% of women and 11.3% of 
men with long-standing cough had asthma diagnosed by a physician. No 
gender diff erence was seen in subjects with attacks of shortness of breath, 
38–39% of them being diagnosed as having asthma.
Seven women and 25 men reported physician-diagnosed asthma among 
the 465 subjects with prick test results. Altogether 18 of those reporting 
asthma (56%) were atopic: 3 women (43%) and 15 men (60%) were atopic. 
One woman and one man reporting physician-diagnosed asthma were 
excluded because of dermographism. Of the 643 participants in the clinical 
part of the study, 70 reported having had asthma at some point in their lives. 
Onset of asthma symptoms was reported by 58 of these subjects. Th e median 
age of onset was 33 years (range 4–63 years).
Table 2. Respiratory symptoms and use of asthma medication by smoking status 









Asthma medication 71.7 76.5 ns 65.6 ns
Attacks of shortness
of breath
72.2 84.7 <0.025 75.4 ns
Long-standing cough 38.5 48.2 ns 47.5 ns
Chronic productive
cough
24.6 35.3 ns 40.2 <0.01
Any wheeze 63.1 81.2 <0.01 80.3 <0.01
5.1.3 Chronic bronchitis
Physician-diagnosed chronic bronchitis or emphysema was reported by 226 
subjects (3.7%): 106 men (4.1%) and 120 women (3.5%). Th e prevalence 
increased with age: 11.5% of men and 8.0% of women aged 60–69 years 
reported physician-diagnosed chronic bronchitis or emphysema. Subjects 
with this condition were highly symptomatic (Table 3). Men signifi cantly 
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more oft en reported wheezing than women. Smoking was strongly associated 
with chronic bronchitis (p<0.001). Of non-smokers, 7.9% reported chronic 
productive cough and 2.1% physician-diagnosed chronic bronchitis. Of 
elderly subjects (60–69 years) reporting chronic productive cough, 61% 
of women and 23% of men were non-smokers. Men reporting bronchitic 
symptoms were more oft en diagnosed as having chronic bronchitis; 15.3% of 
men and 10.1% of women with long-standing cough had physician-diagnosed 
chronic bronchitis. Similarly, 12.8% of men with sputum production versus 
10.0% of women had a diagnosis of chronic bronchitis. Th is diff erence was 
not seen in those reporting chronic productive cough, 19% of whom had 
been diagnosed as chronic bronchitis by a physician.
Table 3. Prevalence (%) of respiratory symptoms among subjects with physician-
diagnosed asthma or chronic bronchitis by gender in Helsinki.
 Men Women p-value
Any wheeze 
in asthma 83.1 71.4 0.011
in chronic bronchitis 77.2 60.2 0.010
Recurrent wheeze
in asthma 48.6 34.0 0.005
in chronic bronchitis 65.7 45.8 0.003
Attacks of shortness of breath 
in asthma 78.4 83.8 ns
in chronic bronchitis 63.7 63.8 ns
Long-standing cough
in asthma 37.9 47.2 ns
in chronic bronchitis 69.2 63.8 ns
Sputum production
in asthma 55.9 53.7 ns
in chronic bronchitis 82.5 80.5 ns
Chronic productive cough
in asthma 53.2 46.3 ns
in chronic bronchitis 70.5 76.5 ns
5.1.4 Risk factors
In the study population of Helsinki, signifi cant risk factors for physician-
diagnosed asthma were having a family history of asthma and female gender. 
Smoking was not a signifi cant risk factor for asthma, but was the main 
risk for chronic productive cough. Having a family history of obstructive 
airway disease (asthma or chronic bronchitis) and belonging to the older 
age group were also signifi cant risk factors for chronic productive cough. 
Belonging to the socio-economic group of manual workers was a signifi cant 




A positive response in skin-prick tests was common, seen in 46.9% of 
all subjects. Subjects aged 26–39 years were most oft en sensitized, with a 
prevalence of 56.8%. Th e most common sensitizing allergen was a dog. Th e 
prevalence of being sensitized diff ered signifi cantly between the three age 
groups of 26–39, 40–49 and 50–60 years (p<0.001). Men were more oft en 
sensitized in all age groups, but this gender diff erence was not signifi cant. 
In the youngest age group, 58.9% of men and 55.2% of women had at least 
one positive prick response, while the respective proportions were 56.9% 
and 42.2% at 40–49 years, and 36.2% and 35.2% at 50–60 years.
Sensitization to any furred animal was most common among the youngest 
in both genders. In the age group 40–49 years, men were signifi cantly 
more oft en sensitized than women to animals (41.4% vs. 21.9%, p=0.02). 
Among the elderly, sensitization to animals was more common in women. 
Sensitization to pollens predominated in women in the youngest age group, 
and in men in the group 40–49 years. Th is diff erence between genders was 
signifi cant among those aged 40–49 years, with 44.8% of men and 23.4% of 
women being sensitized (p=0.012). Sensitization to any of the home dust 
mites or storage mites prevailed among the younger subjects in both genders. 
Th e gender diff erence was signifi cant among the elderly, with 18.8% of men 
and 4.8% of women being sensitized (p=0.003).
Being sensitized to at least four allergens was common among the 
youngest participants, with 23.7% of the sensitized reacting to multiple 
allergens. In the age group 40–49 years, 19.0% of men and 7.8% of women 
were multisensitized, but this diff erence was not statistically signifi cant 
(p=0.068). Elderly men and women were equally multisensitized, with 
altogether 15.7% having multiple responses. Belonging to the youngest 
age group was the strongest risk factor for allergic sensitization (OR 2.15 
[1.35–3.43]), followed by a family history of allergic rhinitis or conjunctivitis 
(OR 1.59 [1.07–2.37]). Th e age group 26–39 years also yielded an increased 
risk for multiple sensitization (OR 4.29 [2.00–9.20]).
5.2 Comparison of Helsinki, Stockholm and Tallinn 
(Study II)
Th e comparison between Helsinki, Stockholm and Tallinn included subjects 
aged 20–64 years; subjects aged 65–69 years were excluded from these 
analyses because the upper age limit in the study in Estonia was 64.
5.2.1 Respiratory symptoms and smoking
Asthma-related symptoms, attacks of shortness of breath and wheezing 
during the last year were most common in Tallinn (Study II: Table 2). Th e 
prevalence of attacks of shortness of breath during the last year among those 
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aged 20–29 years was similar in the capitals: 11.7% in Stockholm, 12.6% 
in Helsinki and 11.8% in Tallinn. In the same age group, wheezing during 
the last year was reported by 17.2% in Stockholm, 22.3% in Helsinki and 
20.1% in Tallinn.
Long-standing cough and sputum production were most common in 
Tallinn, while chronic productive cough was most prevalent in Helsinki 
(Study II: Table 2). Again, with regard to the youngest participants, long-
standing cough was reported by 15.1% in Stockholm, by 18.2% in Helsinki 
and by 22.5% in Tallinn. In the same age group, the prevalence of those 
reporting sputum production was 18.3% in Stockholm, 25.3% in Helsinki 
and 27.4% in Tallinn, and chronic productive cough was reported by 4.8% 
in Stockholm, 8.0% in Helsinki and 6.4% in Tallinn.
Respiratory symptoms (attacks of shortness of breath, wheezing, cough) 
in selected circumstances are presented in Table 4. Dusty environment and 
tobacco smoke were frequent respiratory irritants in all capitals, whereas 
subjects in Helsinki and Stockholm more oft en reported symptoms from 
pollens or animals than in Tallinn.
Table 4. Proportion of subjects (%) reporting respiratory symptoms 
provoked by diff erent factors according to area and gender.
  Helsinki  Stockholm  Tallinn  Difference 
between 
 Men Women Total Men Women Total Men Women Total areas (p-value)
Cold weather 9.6 14.1 12.2 9.2 13.4 11.4 11.7 16.1 14.2 p<0.001
Physical 
exercise 16.1 18.6 17.5 16.2 20.0 18.3 12.0 12.0 12.0 p<0.001
Dusty 
environment 28.4 35.8 32.6 16.5 20.2 18.5 22.1 26.4 24.6 p<0.001
Tobacco 
smoke 16.7 26.6 22.3 16.0 21.9 19.2 22.0 27.3 25.1 p<0.001
Car exhaust 




14.6 26.0 21.1 11.1 17.8 14.7 12.1 20.2 16.8 p<0.001
Pollen 13.7 18.5 16.4 10.6 12.9 11.9 3.2 5.4 4.5 p<0.001
Animals 9.5 12.3 11.1 9.6 10.1 9.9 2.1 3.7 3.1 p<0.001
Smoking habits were similar among women, with around 30% being current 
smokers in all capitals. Heavy smoking (≥15 cigarettes daily) in women was 
more common in Helsinki and Stockholm, 10% each, while the prevalence 
was only 5% in Tallinn. Among men, 32% were smokers in Stockholm, 38% 
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in Helsinki and 57% in Tallinn. Heavy smoking in men was reported by 14% 
in Stockholm, 19% in Helsinki and 26% in Tallinn. All respiratory symptoms 
increased in prevalence with increasing smoking habits in each capital.
5.2.2 Asthma
Physician-diagnosed asthma was most common in Stockholm and least 
common in Tallinn (Study II: Table 2). Th e same diff erences were seen in the 
youngest age group, 20–29 years: physician-diagnosed asthma was reported 
by 5.6% of men and 9.8% of women in Stockholm, 6.1% of men and 6.4% of 
women in Helsinki and 3.7% of men and 2.0% of women in Tallinn.
Among those with physician-diagnosed asthma, attacks of shortness of 
breath during the last year were reported by 75.6% in Helsinki, 71.4% in 
Stockholm and 67.4% in Tallinn. Prevalence of recurrent wheezing in the 
same subjects was 37.6%, 45.4% and 52.6%, respectively. Asthma medication 
was used by 69.7% of these subjects in Helsinki, 75.5% in Stockholm and 
52.0% in Tallinn.
In multiple logistic regression analysis, aft er adjusting for gender, 
smoking, family history of asthma and area of domicile, the strongest risk 
factor for physician-diagnosed asthma was family history of asthma (OR 
3.43 [2.96–3.96]). Living in Stockholm yielded an OR of 3.08 (2.55–3.72), 
and in Helsinki an OR of 2.54 (2.11–3.07) for physician-diagnosed asthma 
as compared with Tallinn. Having a family history of asthma as a risk factor 
for physician-diagnosed asthma diff ered somewhat when calculating risk 
factors separately for the capitals: OR in Stockholm was 3.72 (2.97–4.66), 
in Helsinki 3.41 (2.72–4.28) and in Tallinn 2.69 (1.86–3.88).
5.2.3 Chronic bronchitis
Physician-diagnosed chronic bronchitis was most prevalent in Tallinn and 
least common in Stockholm (Study II: Table 2). Th e prevalence among the 
youngest subjects, aged 20–29 years, diff ered largely between the capitals; 
physician-diagnosed chronic bronchitis was reported by 1.2% of men 
and 1.5% of women in Stockholm, by 0.8% of men and 1.7% of women in 
Helsinki and by 9.4% for men and 6.0% for women in Tallinn. Among those 
with physician-diagnosed chronic bronchitis, long-standing cough was 
reported by 66.0% in Helsinki, 47.2% in Stockholm and 59.5% in Tallinn. 
Th e respective proportions for sputum production were 83.5%, 55.8% and 
64.8%. Chronic productive cough was reported by 62.4% of these subjects 
in Helsinki, 31.3% in Stockholm and 28.6% in Tallinn.
Smoking was a signifi cant risk factor, with OR for heavy smokers being 
2.49 (2.06–3.01) compared with non-smokers. Th e risk increased with age, 
with OR 3.33 (2.63–4.22) for those aged 60–64 years compared with the 
youngest subjects aged 20–29 years. Living in Tallinn yielded an increased 
risk, OR 3.29 (2.72–3.97) compared with Stockholm, but living in Helsinki 
was not a signifi cant risk factor.
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5.3 All centers (Studies III and IV)
Comparisons of all centers were made for subjects aged 20–64 years, which 
comprised 44 483 of the 58 661 persons (76%) invited. Comparison of 
respiratory symptoms between Finland, Estonia and Tallinn revealed a 
pattern similar to that yield in comparing the capitals; respiratory symptoms 
were most common in Estonia, except for chronic productive cough, which 
was most prevalent in Finland (Study IV: Table 3).
In the whole sample of 44 483 subjects, physician-diagnosed asthma 
was more common among women than men: 5.5% versus 5.0% (p=0.013). 
Physician-diagnosed asthma was reported by 5.8% of those aged 20–34 years, 
4.6% of those aged 35–49 years and 5.6% of those aged 50–64 years. In each 
of these age groups, asthma was more common among women than men. 
Also physician-diagnosed chronic bronchitis was more prevalent among 
women (6.4%) than men (5.0%) (p<0.001). Women reported more physician-
diagnosed chronic bronchitis (1517 subjects) than asthma (1322 subjects). 
Among men, 1022 reported physician-diagnosed chronic bronchitis and 1039 
asthma. Prevalences of physician-diagnosed asthma and chronic bronchitis 
by age, gender and country are presented in Table 5. Prevalence estimates 
for both conditions in Finland and Sweden were similar, while chronic 
bronchitis was more common and asthma less common in Estonia.
Table 5. Prevalence of physician-diagnosed asthma and physician-
diagnosed chronic bronchitis by age, gender and country.
  20–34 years 35–49 years  50–64 years  
  Men Women  Men Women  Men Women  Total*
% % % % % % %
Sweden asthma 8.4 9.5 7.0 7.7 6.8 7.3 7.8
chronic bronchitis 1.3 2.0 2.6 3.5 4.2 5.5 3.1
Finland asthma 5.7 5.9 4.1 5.8 6.6 7.9 5.9
chronic bronchitis 1.2 1.6 2.6 2.7 5.7 4.7 2.9
Estonia asthma 2.0 1.7 1.6 1.5 1.9 3.4 2.0
chronic bronchitis 8.7 7.6 8.2 10.8 11.7 16.7 10.7
* Th e prevalence of asthma (p<0.001) and of chronic bronchitis (p<0.001) diff ered 
signifi cantly between countries calculated by chi square test.
Although diagnosed asthma was more common among women, recurrent 
wheezing and any wheezing were signifi cantly more common among men. 
Any wheezing was reported by 19.8% of men and 18.8% of women, and 
the respective rates for recurrent wheezing were 11.0% and 9.8%. On the 
other hand, attacks of shortness of breath were more common in women, 
13.1%, than in men, 11.3% (p<0.001), as was long-standing cough. No 
diff erence in sputum production was seen, but chronic productive cough 
was more common in men, 9.2%, than in women, 8.0% (p<0.001). All of 
5 Results 43
these symptoms were most prevalent in the age group of 50–64 years than 
in the two younger age groups in both genders.
Comparing symptom levels among women in diff erent countries showed 
that the prevalence of attacks of shortness of breath was similar, around 
13%. Wheezing was most common among Estonian women, with 12.4% 
reporting recurrent wheezing and 20.3% any wheezing. Long-standing 
cough, 25.9%, and sputum production, 29.6%, also predominated among 
Estonian women, while chronic productive cough was most common in 
Finnish women, 10.7%. Among men, asthma-related symptoms, attacks of 
shortness of breath and wheezing were most common in Estonia, as were 
sputum production and long-standing cough. Chronic productive cough 
was most common in Finnish men.
Analyses in the whole study population revealed a high prevalence of 
chronic respiratory symptoms in the socio-economic groups of manual 
workers in industry and in service in each country (Study III: Table 3). 
Th ere were signifi cantly more manual workers in industry and fewer in 
service in both genders in Estonia than in Finland or Sweden. In particular, 
women working as manual workers in industry had high rates of respiratory 
symptoms; long-standing cough was reported by 26.0% of women and 18.5% 
of men (p<0.001). Sputum production was found in 32.2% of women and 
27.4% of men (p<0.001). Recurrent wheezing was also more common in 
women, 16.3%, than in men, 14.5%, working in industry (p=0.0138), as was 
any wheezing. Long-standing cough was most frequent in Estonian manual 
workers in industry, 25.5%, while the rates were 18.9% in Finland and 11.9% 
in Sweden. Recurrent wheezing was also most common in Estonia in the 
same socio-economic group, 18.3%, while the rates were 9.4% in Finland and 
12.3% in Sweden. Prevalences of diff erent respiratory symptoms reported 
by subjects with physician-diagnosed asthma and chronic bronchitis are 
presented in Table 6.
Table 6. Prevalence (%) of respiratory symptoms among subjects having physician-
diagnosed asthma and physician-diagnosed chronic bronchitis in Finland, Sweden, 
and Estonia by gender.
 Finland  Sweden  Estonia
 Men Women  Men Women  Men Women
Wheezing
in asthma 74.6 69.6 66.6 69.8 65.0 73.9
in chronic bronchitis 72.7* 58.2* 55.3 56.2 61.4* 52.5*
Attacks of shortness of breath
in asthma 73.9 78.4 67.9* 75.8* 62.6 72.9
in chronic bronchitis 55.3 55.5 53.5 53.9 42.2 40.0
Sputum production
in asthma 56.1 57.6 45.9 45.6 63.4 62.8
in chronic bronchitis 83.9 77.5 64.2 59.9 67.6 64.9
Chronic productive cough
in asthma 32.4 29.9 21.8 20.0 31.7 29.8
in chronic bronchitis 57.1 56.0 35.8 33.8 35.7** 27.3**
Gender diff erences by chi-square test. Signifi cant diff erence in p-value: *=p<0.01; **=p<0.001. 
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6 Discussion
6.1 Discussion of methodology
Th e FinEsS postal questionnaire is based on the OLIN questionnaire 
(Lundbäck 1991, 1993), which was developed from international 
questionnaires, including the ATS (Ferris 1978), the revised British Medical 
Research Council questionnaire (MRC 1960), the IUATLD (Burney et 
al. 1989) and the Tucson studies questionnaires (Lebowitz et al. 1995). 
Th e original questionnaires have been validated in many studies and also 
reviewed (Burney et al. 1989, Torén et al. 1993). Apart from its use in the 
OLIN studies, the OLIN questionnaire has been used in other Swedish 
studies throughout the country (Larsson L et al. 1993, Montnémery et al. 
1998, 2001, Hasselgren et al. 2001).
Th e study sample was obtained from population registers in a random 
manner in each of the countries. Th is procedure controls the risk of selection 
bias. Th e total sample in the postal questionnaire in Helsinki was 8000, 
exceeding the populations used in the ECRHS, which varied from 3000 to 
6734 (ECRHS 1996). Th e ECRHS protocol recommends inviting at least 
3000 subjects for their questionnaire study and at least 600 subjects for the 
clinical component (Burney et al. 1994). All FinEsS centres had large study 
populations and exceeded the ECRHS recommendations. Th e sample size 
for the clinical component in Helsinki was limited to 1200 due to restricted 
resources. Despite this limitation, analysis of data from single centres are 
useful when estimating prevalence of, for instance allergic sensitization, 
BHR, and COPD, although comparisons of prevalence levels between centres 
are limited.
Good response rates were obtained in the postal survey, the total 
participation rate in Helsinki being 76% of the original study sample, which 
is similar to the median participation rate in the ECRHS (ECRHS 1996). 
Young men were least likely to participate. Th e satisfactory response rate 
reduces the risk of non-response bias. A non-responder analysis was also 
carried out in northern Finland in the FinEsS; typical non-responders were 
young male smokers. Th e reasons for not responding were lack of interest 
and forgetting to mail back the response. In conclusion, only the rate of 
current smoking was slightly biased by non-responders (Kotaniemi et al. 
2001). Similarly, in a non-responder analysis from the OLIN studies, young 
male smokers were most likely not to participate (Rönmark et al. 1999b). 
Th eir report concluded that the prevalence of respiratory symptoms and 
diseases might even be slightly underestimated due to non-responders.
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Comparison of diagnostic diff erences based on questionnaire data is not 
defi nitive, but it does large samples to be compared. Defi nitive comparison 
would require a careful examination of subjects, multiple lung function 
measurements, allergy testing, examination of earlier medical records and 
fi nally a physician`s conclusion of the diagnosis. Th is would be impossible 
in large-scale studies. Th e lack of a gold standard for asthma also makes 
comparisons diffi  cult. BHR has oft en been used as a marker of asthma, 
but it has been shown to have a lower sensitivity than assessment based on 
symptoms in relation to clinical examination by a physician or a previous 
diagnosis of asthma (Pekkanen and Pearce, 1999). A recent review by the 
GINA Committee stated that the ECHRS question on wheezing during 
the last year, which was included in our questionnaire as well, is useful for 
detecting the prevalence of “clinical asthma” (Masoli et al. 2004). Pekkanen 
et al. (2005) agreed that wheezing in the last 12 months yielded the best 
combination of sensitivity and specifi city when assessing prevalence of 
asthma with diff erent questions and combinations of questions. Th e question 
on physician-diagnosed asthma had the highest positive predictive value, 
0.82, in validation of diff erent questions in relation to confi rmed asthma by 
a chest physician interview with data on BHR and spirometry (Kilpeläinen 
et al. 2001). Th e specifi city was high, 99%, but the sensitivity remained low, 
36%.
Th e same problems are faced when diagnosing chronic bronchitis and 
COPD. A recent review on the prevalence of COPD worldwide concluded 
that comparison of prevalence rates was diffi  cult due to variable diagnostic 
criteria, including diff erent guidelines for diagnosis, and potential diagnostic 
bias (Halbert et al. 2003). Many studies assessed in that review, including our 
study, used criteria for chronic bronchitis compatible with that of the British 
Medical Research Council, i.e. productive cough on most days of the week for 
at least 3 months of the years in 2 successive years, with other causes excluded 
(MRC 1965). Th is corresponds to stage 0 in the GOLD criteria. In addition 
to being a disturbing symptom, chronic productive cough is associated with 
a faster decline in lung function, and thus, should be recognized as early as 
possible (Vestbo et al. 1996). A primary care study from the Netherlands 
revealed that chronic cough was a good predictor of airfl ow obstruction 
compared with other symptoms, and half of smokers aged over 60 years with 
cough had airway obstruction (van Schayck et al. 2002).
Questions on the main and current occupation were posed to assess 
socio-economic status. Socio-economic classifi cation can be made based 
on occupation, education or income. In the Nordic countries, the level 
of education is usually high and diff erences between income levels low 
compared with the situation internationally. Occupation-based classifi cation 
is subject to healthy worker bias. Th e classifi cation used in our study is based 
on the main occupation in addition to the present one, which reduces the 
possibility of this bias.
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Skin-prick tests are a practical method to assess atopy and are applied in 
routine practice. Total IgE has been used in some studies, but the ECRHS 
concluded that variations in prevalence of atopy and the level of IgE are 
independent of each other (Burney et al. 1997). Here, prick tests were 
performed by trained and experienced nurses. Th e skin test methods and 
allergens were the same in all centres.
6.2 Discussion of main results
6.2.1 Diagnostic labelling of obstructive airway diseases
Numerous studies have been performed on prevalence of asthma and 
diff erences in prevalence in various parts of the world. In the ECRHS, wide 
variation in occurrence of respiratory symptoms and physician-diagnosed 
asthma was noted between countries and even within countries (ECRHS 
1996, Janson et al. 1997). Th e highest prevalences were generally found 
in the English-speaking countries; however, the prevalence for current 
asthma symptoms was among the highest in Estonia, even higher than 
in New Zealand and England (Masoli et al. 2004). An example of wide 
variation within a country is Spain, where the prevalence of wheezing during 
the previous year varied from 16% to 29% (ECRHS 1996). Comparison 
of adults from former West and East Germany, including questionnaire 
data, lung function and allergy testing, showed a higher prevalence of lung 
function impairment, BHR and atopy in the West, with rates of respiratory 
symptoms also being higher (Nowak et al. 1996). Comparison of adults in 
Sweden and in Estonia as part of the ECRHS showed wheezing, waking with 
chest tightness, waking with attacks of shortness of breath and waking with 
attacks of cough to be signifi cantly more common in Tartu, Estonia, than in 
Uppsala, Sweden. Of the symptoms, only breathlessness while wheezing was 
signifi cantly more common in Uppsala, and no signifi cant diff erence was 
found for wheezing without cold, but still the authors concluded that the 
prevalence of symptoms suggesting current asthma was higher in Uppsala 
based on these two questions (Jõgi et al. 1996). Further, it was later shown 
that BHR to methacoline was more common in Tartu than in Uppsala (Jõgi 
et al. 2004).
Th e question regarding wheezing during the previous year from the 
ECRHS was included in the FinEsS questionnaire and referred to as “any 
wheeze”. As in the ECRHS, any wheeze was more common in Estonia than in 
Sweden in our study, but the prevalence was somewhat lower. In the ECRHS, 
the prevalence of most symptoms in Tartu was higher than the median, 
while the rates for diagnosed asthma or asthma attack were lower than the 
median, which was consistent with our results. Our fi ndings on symptom 
levels are also in agreement; oft en the highest prevalence of respiratory 
symptoms was found in Estonia rather than in Finland or Sweden. Our 
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conclusions are that asthma-related symptoms are highest in Estonia, but a 
signifi cantly smaller proportion of subjects with the same symptoms have 
been diagnosed as having asthma compared with Finland and Sweden. Even 
young subjects (aged 20–30 years) with common asthma symptoms were 
diagnosed as chronic bronchitis in Estonia. High prevalence of smoking in 
Estonian men may contribute to these diff erences, but smoking is equally 
common among women in the three countries, and heavy smoking is the 
least common among Estonian women. Moreover, respiratory symptoms 
in Eastern Europe may easily be interpreted as bronchitic symptoms (von 
Mutius et al. 1992,1994). On the other hand, one-third of non-smoking 
Estonian women were exposed to environmental tobacco smoke (ETS) at 
home, and half of the men outside of the home (Larsson ML et al. 2003). 
Women were more troubled by ETS, but exposure at home was not related 
to increased risk for respiratory symptoms. ETS exposure of more than fi ve 
hours daily outside the home environment yielded an increased risk for 
wheezing and physician-diagnosed asthma.
Diagnostic labelling of obstructive airway diseases in Estonia has been 
infl uenced by the former Soviet Union traditions; asthma used to be defi ned 
as an allergic disease, and subjects with asthma faced restrictions in their lives 
including traveling abroad, which could have made the diagnosis unpopular 
(Meren et al. 2001, Jannus-Pruljan et al. 2004). However, when defi ning 
asthma using symptom combinations together with BHR, the prevalence of 
asthma in Estonia would be around 5–8% (Meren et al. 2005). A diagnostic 
diff erence in asthma was suspected among children between Poland and 
Sweden already more than 10 years ago; asthma-related symptoms and 
diurnal peak expiratory fl ow (PEF) variability were more common, while 
asthma diagnosed by a doctor was much less common in Poland than in 
Sweden (Bråbäck et al. 1994). In this work, however, attention was directed to 
the large diff erences in atopy between counties, and less to results concerning 
asthma. Th e same pattern was found in our study in adults, suggesting a 
diagnostic diff erence of obstructive airway diseases. Th ese diff erences are 
hardly surprising in view of the lack of a gold standard in diagnostics of 
these diseases. Th e latest ECRHS II results indicate increased prevalence 
rates of asthma attacks and diagnosed asthma, but no change in asthma-
related symptoms (Chinn et al. 2004). An increased labelling of mild asthma 
or increased use of asthma medication was suspected. Attention should be 
focused on implementing uniform guidelines, at least within the European 
Community level.
Large diff erences in smoking habits were found between Finnish, 
Swedish and Estonian men. Only a small proportion of subjects reporting 
chronic productive cough in Sweden, Finland and Estonia, reported 
having physician-diagnosed chronic bronchitis, suggesting a considerable 
underdiagnosis of chronic bronchitis (Study IV: Figure 3). Th e OLIN studies 
have earlier showed similar results; only 23–25% of those with chronic 
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bronchitis had been diagnosed as having chronic bronchitis, emphysema 
or COPD prior to the study (Lindström et al. 2001). Similarly, in a French 
study, 24% of subjects with chronic bronchitis were diagnosed as having 
chronic bronchitis, and only 7.2% had a follow-up scheduled (Huchon 
et al. 2002). Data from Spain and the US were also consistent with the 
theory of considerable underdiagnosis of these conditions (Mannino et al. 
2000, Peña et al. 2000). Th us, while chronic bronchitis can be detected with 
simple questioning on cough and smoking, its symptoms appear to receive 
inadequate attention from physicians, with most aff ected subjects remaining 
unidentifi ed and without treatment (van Schayck et al. 2002). An interesting 
feature is that the levels of underdiagnosis in Sweden, Finland, France and 
the US are similar.
Th e high level of respiratory symptoms in each of the countries was 
worrisome and raised the question of whether suffi  cient resources are 
given to basic health care to take care of patients with these symptoms, 
and whether general practitioners are well-trained to identify asthma and 
chronic bronchitis. In a study on identifying these diseases in patients with 
persistent cough in the Netherlands, nearly half of the subjects with cough 
received a diagnosis of asthma or chronic bronchitis when properly assessed. 
Th e authors mentioned that 10% of visits to a general practitioner are made 
because of cough, and in most cases the diagnosis given is acute bronchitis or 
upper respiratory tract infection, while the diagnoses of asthma and chronic 
bronchitis are rarely considered (Th iadens et al. 1998).
Comparisons between countries are oft en based on questions about 
diagnosed asthma. Th is procedure is biased by diagnostic practices and 
public awareness. Repeated questioning of symptoms and earlier lung 
function measurement have been thought to increase awareness and 
reporting of respiratory symptoms, although this was not confi rmed in 
a survey comparing a longitudinal and a cross-sectional study (Sears et 
al. 1997). BHR has also been used in comparisons, but it should be borne 
in mind that while it is specifi c it is not sensitive, even when combined 
with questions on asthma-like symptoms (de Marco et al. 1998). In this 
Italian component of the ECRHS, only one-third of subjects with obvious 
asthma were aware of it based on judgement of specialists (de Marco et al. 
1998). However, practically no studies assessing diagnostic practices in 
adults exist although it has been stated that: “ Th e prevalence of asthma is 
diffi  cult to follow over time owing to changes in diagnostic practice” (Magnus 
and Jaakkola 1997). Th e GINA Committee decided to assess diff erences 
in asthma prevalence worldwide based on wheezing during the last year 
instead of by comparing physician-diagnosed asthma, asthma medication, 
or asthma attacks because of “the marked variation in the recognition and 
presentation to a doctor by an individual with recurrent wheezing episodes” 
(Masoli et al. 2004).
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6.2.2 Risk factors for respiratory conditions and allergic 
sensitization
Family history of asthma was a strong risk factor for asthma in Helsinki, 
OR 3.32, which is consistent with results of the OLIN studies from Sweden, 
with a similar slightly increased risk for women as compared with men 
(Rönmark et al. 1997). Smoking was a greater risk factor for asthma in the 
OLIN studies than in our study, although smoking habits were assessed with 
the same questions. Th e strongest risk factor for chronic productive cough 
in Finland, Sweden and Estonia was heavy smoking. In Finland, women 
had a slightly higher risk for sputum production and chronic productive 
cough than men. Women have been shown to be more vulnerable to tobacco 
smoke and more susceptible to respiratory symptoms than men, although 
the reasons underlying this gender diff erence remain obscure (Langhammer 
et al. 2003). Family history of obstructive airway diseases doubled the risk 
for chronic productive cough in all three countries (Study III: Table 5). 
Recently, in a Swedish study, a family history of chronic bronchitis was found 
to be a signifi cant risk factor for chronic bronchitis or COPD, with an OR 
of 2.80 (Nihlén et al. 2003). Besides genetic factors, this increased risk may 
be due to shared environmental and socio-economic factors, perhaps also 
to exposure to environmental tobacco smoke in families with members that 
have chronic obstructive lung disease.
Socio-economic risk factors associated with the main occupation revealed 
low socio-economic status to be a signifi cant risk factor for respiratory 
symptoms in all three countries. Th is low socio-economic group comprises 
manual workers in industry and in service, including many occupations, 
such as cleaners, with a well-known risk for asthma (Kogevinas et al. 1999, 
Karjalainen et al. 2001, Zock et al. 2002). Our fi ndings confi rmed that being 
a manual worker was associated with an increased risk for the respiratory 
symptoms common in asthma and chronic bronchitis independently of 
smoking habits. A similar increased risk for bronchitic symptoms among 
manual workers has been found in northern Sweden (Lundbäck et al. 
2001). Occupational exposures are oft en underestimated in asthma and 
frequently remain undetected in chronic bronchitis. Socio-economic status 
also includes factors other than occupation, such as housing, diet, economic 
position, educational level and environmental factors. In low socio-economic 
groups, housing conditions may be poorer and the home environment may 
be situated in more polluted areas than in higher socio-economic groups. 
Further, smoking is more common in low socio-economic groups, and 
exposure to environmental tobacco smoke is therefore also more likely. 
Many risk factors are thus clustered in low socio-economic groups, and 
their eff ects may be additive.
Recently, in a large study from Sweden, a reduced risk for allergic rhinitis 
was found for those conscripts who were raised on a farm or in a rural 
environment (Bråbäck et al. 2004). In our study, childhood environment 
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was assessed by asking whether the subject had resided in the countryside, 
in a suburban environment or in town during the fi rst fi ve years of life. 
Th us, living on a farm was not specifi cally enquired about. In risk factor 
analysis, urban living yielded an increased risk for sensitization to pollens, 
but not to animals. A clearer diff erence between the groups might have been 
emerged had we enquired about farm living, but otherwise our fi ndings are 
consistent with earlier results.
6.2.3 Asthma, chronic bronchitis and respiratory symptoms in 
relation to earlier studies
Respiratory symptoms in Sweden were somewhat more common than 
previously reported (Lundbäck et al. 1991, Larsson et al. 1993). Th e 
prevalence of physician-diagnosed asthma in Sweden, 7.8%, was similar, 
and physician-diagnosed chronic bronchitis, 3.1%, lower than in the 
OLIN studies (Lundbäck et al. 1993, Rönmark et al. 1997). In Finland, 
the prevalence of asthma was higher than in earlier studies (Alanko 1970, 
Heinonen et al. 1987, Haahtela et al. 1990, Varjonen et al. 1992, Isoaho et 
al. 1994, Hedman et al. 1999). In the study by Hedman et al. (1999) based 
on 3102 responses to a mailed questionnaire from subjects aged 18–65 
years, physician-diagnosed asthma was reported by 5.3%. Th e prevalence of 
physician-diagnosed chronic bronchitis in their study was exactly the same, 
3.7%, as our result from Helsinki, but clearly lower than in the study by von 
Hertzen et al. (2000) and in earlier studies from the 1960s (Huhti 1965). In 
Finland, chronic bronchitis was more common than asthma some decades 
ago. Since then, however, asthma has become more prevalent; some of the 
conditions that may earlier have been diagnosed as chronic bronchitis may 
today be diagnosed as asthma. In Estonia, the prevalence of asthma was 
similar to that in the ECRHS, but the prevalence of chronic bronchitis was 
higher than in the 1980s (Utkin et al. 1989, ECRHS 1996).
Respiratory symptoms in Helsinki were surprisingly common; nearly 
one-third of subjects had sputum production, one-quarter had tightness 
in the chest awakening and one-fi ft h wheezing. An alarming prevalence of 
symptoms was also found in subjects with diagnosed obstructive airway 
diseases. Th e goals of asthma management were not achieved with more than 
70% of asthmatics suff ering from attacks of shortness of breath and wheezing 
during the previous year in Helsinki (Dahl and Bjermer 2000, Haahtela et 
al. 2001). Similarly, a comparison of asthma management across Europe 
revealed that asthma control was suboptimal in each of the seven countries 
evaluated, including Sweden (Vermeire et al. 2002). Our comparison of 
symptom levels in subjects reporting asthma showed no diff erences in 
levels of wheezing or attacks of shortness of breath between countries, but 
symptom levels overall were very high, suggesting undertreatment in all 
three countries (Table 6).
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Bronchitic symptoms were also common in the age group 20–64 years; 
chronic productive cough was reported by 11.0% in Finland, 9.4% in Estonia 
and 6.2% in Sweden. Levels of sputum production and chronic productive 
cough were higher among those who reported having chronic bronchitis in 
Finland than in Sweden and Estonia, which also suggests undertreatment 
(Table 6). Bronchitic symptoms have been even more common in Finland 
in earlier studies (Huhti 1965, von Hertzen et al. 2000). In both of these 
studies, the prevalence of chronic bronchitis in men was more than 20% 
and in women 5.5–7%. Th e high prevalence in men during the 1960s was 
infl uenced by the high prevalence of smoking at that time and smoking being 
even more common before the 1960s. Th e high prevalence in the study by 
von Hertzen et al. (2000) was probably due to the inclusion of older subjects 
than ours; the prevalences of chronic bronchitis and COPD rise steeply with 
older age (Lundbäck et al. 2003b).
Respiratory symptoms were associated with smoking and increasing age. 
Recently, a study from Norway showed benefi cial eff ects of smoking cessation 
on several asthma- and chronic bronchitis-related respiratory symptoms 
(Eagan et al. 2004). In the same study, increasing age, heavier smoking 
history and prior exposure to fumes or dusts predicted lower alleviation of 
symptoms. Th e most common irritant factor causing respiratory symptoms 
in Helsinki was dust, as also reported in an earlier study in Finland (Heinonen 
et al. 1987). Dust and tobacco smoke were the most common irritants in 
each capital, while symptoms associated with exposure to pollens or animals 
were reported less frequently in Tallinn than in Helsinki or Stockholm. Th is 
could be explained by sensitization to pollen and furred animals being less 
common in Tallinn (Raukas-Kivioja et al. 2003).
6.2.4 Allergic sensitization in Helsinki 
Allergic sensitization was common in our study, 47%, with men more 
oft en being sensitized than women. Th e majority of young adults aged 
26–39 years were sensitized to at least one allergen, with 42% of sensitized 
individuals responding to multiple allergens. Similarly in the ECRHS, IgE 
levels decreased with age and were higher in men (Burney et al. 1997). In an 
earlier study on skin-prick test reactivity, a relationship between reactivity 
and age was apparent, with the peak prevalence of reactivity (more than 40%) 
occurring during the third decade (Barbee et al. 1976). Th e FinEsS study 
results from Tallinn also showed the youngest subjects most oft en being 
sensitized (Raukas-Kivioja et al. 2003). Sensitization to multiple allergens was 
strongly associated with physician-diagnosed asthma, wheezing and allergic 
rhinoconjunctivitis, which was a very interesting feature and in concordance 
with clinical experiences. Multiple sensitization has earlier been associated 
with BHR in adults (Kerkhof et al. 2003). Th e prevalence of asthma rose 
with an increasing number of positive skin-prick test responses, a fi nding 
previously demonstrated in children (Sears et al. 1993). Th e prevalence of 
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allergic rhinoconjunctivitis also rose with an increasing number of positive 
skin-prick test responses, which has been shown in children as well (Sears et 
al. 1993). Urban living during childhood yielded an increased risk for allergic 
sensitization, concordant to earlier results of a childhood farm environment 
being protective against allergic sensitization in adulthood (Kilpeläinen et 
al. 2000, Leynaert et al. 2001).
Th e distribution of responses to diff erent allergens was similar to 
earlier studies in Finland, with dogs, cats, birch and timothy being the 
most common sensitizers (Vartiainen et al. 2002). Surprisingly, 10% of 
subjects were sensitized to cockroaches, although these are not found 
in homes in Helsinki. Similarly, in an earlier study from eastern Finland 
7.2% of participants had positive responses to cockroaches in skin-prick 
tests (Vartiainen et al. 2002). Th e cockroach was also found to be the most 
common sensitizer in Estonia, and sensitization to the cockroach was 
signifi cantly associated with respiratory symptoms common in asthma 
(Raukas-Kivioja et al. 2003). Reactions to cockroaches could be the result of 
cross-reactivity to house dust mites or storage mites (Sidenius et al. 2001). 
Possibly, some of the sensitization to storage mites and cockroaches could 
have happened abroad, for example, in Spain, which is a popular travel 
destination. Storage mites are common sensitizers in Spain, as are house 
dust mites (Vidal et al. 2004). In our study, oft en subjects with positive 
responses to cockroaches had vacationed in Spain. Similarly, in a recent 
report on subjects with sensitization to house dust mites in Reykjavik, no 
signifi cant exposure in subjects` homes could be verifi ed, and the authors 
suspected exposure abroad or an unidentifi ed exposure in an environment 
other than the home (Hallas et al. 2004).
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7 Conclusions
1. Respiratory symptoms were common in the adult population of Helsinki. 
Compared with earlier Finnish studies, a higher prevalence of physician-
diagnosed asthma, 6.6%, and a lower prevalence of physician-diagnosed 
chronic bronchitis, 3.7%, were found in Helsinki. Family history of asthma 
was the strongest risk factor for physician-diagnosed asthma (OR 3.3). 
Female gender also yielded an increased risk for asthma (OR 1.3). A 
considerable underdiagnosis of chronic bronchitis was noted; only 19% 
of those reporting chronic productive cough had physician-diagnosed 
chronic bronchitis. Th e risk factors for chronic productive cough were 
smoking, family history of obstructive airway disease, age >44 years and 
being a manual worker.
2. Th e comparison between Helsinki, Stockholm and Tallinn in subjects aged 
20–64 years revealed physician-diagnosed asthma to be most common 
in Stockholm, 7.6%, while the prevalence in Helsinki was 6.2% and in 
Tallinn 2.3%. Asthma-related symptoms were, however, most common 
in Tallinn. Physician-diagnosed chronic bronchitis showed an inverse 
pattern, with prevalences of 10.6% in Tallinn, 3.4% in Helsinki and 3.0% 
in Stockholm. Chronic productive cough was most common in Helsinki. 
Subjects with symptoms commonly occurring in asthma were more likely 
to have a diagnosis of asthma in Helsinki and Stockholm than in Tallinn; 
the diagnosis of chronic bronchitis was favoured in Tallinn.
3. Comparison of all data on subjects aged 20–64 years in Finland, Sweden 
and Estonia revealed that belonging to the socio-economic group of 
manual workers was associated with an increased risk for chronic 
respiratory symptoms independently of smoking habits in each country. 
Comparison of risk factor profi les for respiratory symptoms between the 
countries showed a similar pattern, except that Estonian women were at 
higher risk than the others.
4. Comparison of diagnostic practices revealed a higher likelihood of 
asthma diagnosis and a lower likelihood of chronic bronchitis diagnosis in 
relation to respiratory symptoms in Finland and Sweden than in Estonia, 
suggesting a diff erence in diagnostic labelling between Estonia and the 
two other countries. Th e results indicate that asthma was considerably 
underdiagnosed in Estonia.
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5. Th e prevalence of allergic sensitization in Helsinki was high, with 47% 
of subjects aged 26–60 years and 57% of subjects aged 26–39 years being 
sensitized to at least one allergen. Multiple sensitization was surprisingly 
common among the youngest age group (26–39 years), with 42% of 
the sensitized having at least four responses in skin-prick tests, while 
only 16% of those aged 50–60 years were multisensitized. Multiple 
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   Kyllä  Ei / En tiedä 
1. Onko jollakin vanhemmistasi tai sisaruksistasi ?   
 a) astmaa    
 b) allergista nuhaa (esim. heinänuhaa) tai allergista silmävaivaa  
 c) kroonista keuhkoputkentulehdusta tai keuhkonlaajentumaa  
    
2. Onko Sinulla nyt tai onko Sinulla ollut aiemmin ?   
 a) astmaa    
 b) allergista nuhaa (esim. heinänuhaa) tai allergista silmävaivaa  
 c) kroonista keuhkoputkentulehdusta tai keuhkonlaajentumaa  
 d) muu keuhko- tai hengityselinsairaus, mikä ?   
 kirjoita vastaus tähän:   
    
3. Onko lääkäri todennut Sinulla olevan astmaa ?   
    
4. Onko lääkäri todennut Sinulla olevan kroonista (pitkäaikaista)  
    kroonista keuhkoputkentulehdusta tai keuhkonlaajentumaa ?  
    
5. Käytätkö astmalääkkeitä ? Mitä lääkettä:   
    
6. Onko Sinulla ollut astmaoireita nykyisin tai viimeisen 10 vuoden aikana ?  
    (ajoittain hengenahdistusta tai hengenahdistuskohtauksia, samanaikaisesti  
    voi olla yskää tai hengityksen vinkumista)   
Jos vastasit kyllä:    
 a) Onko sinulla ollut astmaoireita viimeisten 12 kuukauden aikana ?  
    
7. Onko Sinulla ollut viime vuosina pitkäaikaista yskää ?   
    
8. Nouseeko yskiessä keuhkoistasi yleensä limaa tai onko keuhkoissa   
    limaa, jota on vaikea saada irtoamaan ?   
Jos vastasit kyllä:    
 a) onko limaa noussut useimpina päivinä vähintään kolmen  
  peräkkäisen kuukauden aikana?   
 b) onko tällaisia vähintään kolmen kuukauden limannousujaksoja  
  ollut vähintään kahtena peräkkäisenä vuonna?   
    
9. Onko tavallista, että keuhkoissa hengityksesi rahisee äänekkäästi tai vinkuu?   
    
10. Onko sinulla ollut hengityksen vinkunaa kertaakaan viimeisen  
     12 kuukauden aikana ?    
Jos vastasit kyllä:    
 a) oliko Sinulla ollenkaan hengenahdistusta vinkunan yhteydessä ?  
 b) oliko Sinulla hengityksen vinkunaa vaikka et ollut flunssassa ?  
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   Kyllä  Ei / En tiedä 
11. Oletko viimeisten 12 kuukauden aikana herätessäsi kertaakaan kokenut  
 hengityksesi olevan tukossa (keuhkoissa)?   
    
12. Hengästytkö tai joudutko hengästymisen vuoksi kävelemään hitaammin  
 kuin muut, kun kävelet ikäistesi henkilöiden kanssa tasamaalla normaali-  
 vauhdilla?    
    
13. Saatko hengenahdistusta, hengityksen vinkunaa tai vaikeita yskänpuuskia?  
 a) rasituksessa    
 b) kylmässä    
 c) pakkasessa rasituksen yhteydessä   
 d) pölyisissä olosuhteissa   
 e) tupakansavusta    
 f) autojen pakokaasuista   
 g) voimakkaista tuoksuista (esim. deodorantit, mausteet, painomuste,  
    puhdistusaineet, kukkien tuoksut tms.)   
 h) kasvien tai puiden siitepölyistä   
 i) ollessasi tekemisissä eläinten kanssa   
    
14. Tupakoitko tai poltatko piippua tai sikareita?   
 (vastaa kyllä vaikka olisitkin lopettanut viimeisten 12 kuukauden aikana)  
 Jos vastasit kyllä:    
 a) Kuinka monta savukellista, sätkää, sikaria tai piipullista olet  
     polttanut keskimäärin vuorokaudessa? a) vähemmän kuin 5 kpl  
                                                                 b) 5-14 kpl   
                                                                 c) 15 kpl tai enemmän  
 Jos vastasit ei:    
b) Oletko aiemmin ollut tupakoitsija, mutta lopetit yli vuosi sitten?  
    
15. Missä ammatissa olet pääasiassa toiminut?   
 kirjoita vastaus tähän:    
 a) montako vuotta olet yhteensä ollut tässä työssä: vuotta  
    
16. Onko Sinulla nykyisin muu työ tai tehtävä ( muu ammatti, opiskelu, työtön,    
 kotityö, eläke, sairauseläke tms.)?   
 jos on niin mikä?, kirjoita vastaus tähän:   
 a) montako vuotta olet yhteensä ollut tässä työssä, eläkkeellä, tms.:     vuotta  
17. Onko nykyinen työsi pääasiassa    a) ulkotyötä?   
                                                             b) sisätyötä?   
18. Kuinka monta vuotta yhteensä olet ollut pääasiassa ulkotyössä?       vuotta  
    
19. Oliko      a) äitisi tupakoitsija lapsuutesi aikana?   
                    b) isäsi tupakoitsija lapsuutesi aikana?   
20. Oletko tai oletko ollut kilpahiihtäjä tai säännöllinen kuntohiihtäjä?  
    
VASTAA TARKASTI - KIITOKSET AVUSTASI! 
päiväys:                             puhelinnumerosi:   
Allekirjoitus:    
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Appendix 2
FinEsS-questionnaire in English 
   Yes  No / I don’t 
know 
1. Have any of your parents, brothers or sisters ?   
 a) asthma    
 b) allergic eye-/nose catarrh (hay fever)   
 c) chronic bronchitis or emphysema   
    
2. Have you now or have you had any of the following diseases ?  
 a) asthma    
 b) allergic eye-/nose catarrh (hay fever)   
 c) chronic bronchitis or emphysema   
 d) any other lung or airways diseases - if "yes", which ?   
    
3. Have you been diagnosed by a doctor as having asthma ?   
    
4. Have you been diagnosed as having chronic bronchitis or emphysema by a doctor?  
    
5. Do you currently use asthma medicines (permanently or as needed)?:  
        
6. Have you now or have you had asthma symptoms during the last 10 years   
    (intermittent breathlessness) or attacks of breathlessness?   
 The symptoms may exist simultaneously with or without cough or wheezing.  
If "yes":    
 a) Have you had these symptoms during the last year (the last 12 months) ?  
    
7. Have you had longstanding cough during the last years?   
    
8. Do you usually have phlegm when coughing, or do you   
    have phlegm which is difficult to bring up?    
If "yes":    
 a) do you bring up phlegm on most days during periods of at least   
  successive three months?   
 b) Have you had such periods during at least   
  two successive years?   
    
9. Have you had wheezing, whistling, or a noisy sound in your chest when breathing?  
    
10. Have you had wheezing or whistling in your chest at any time in the last  
     12 months?    
If "yes":    
 a) Have you been at all breathless when the wheezing noise was present ?  
    
 b) Have you had this wheezing or whistling when you did not have a cold ?  
    
11. Have you awakened with a feeling of tightness in your chest  
 at any time in the last 12 months?   
    
12. Do you have to walk slower than other people of your age on the level  
 because of breathlessness?   
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   Yes  No / I don’t 
know 
13. Do you usually have breathlessness, wheeze, or severe cough:  
 a) on effort    
 b) in cold weather    
 c) on effort in cold weather during winter   
 d) in dusty places    
 e) from cigarette or tobacco smoke   
 f) from car exhaust fumes   
 g) from strong smelling scents (perfumes, spices, printing ink,  
    cleaner,strong smelling flowers)   
 h) from pollens    
 i) from animal with fur (cat, dog, horse,cow)   
    
14. Do you smoke? (Smokers also include those who smoke a few cigarettes or  
 pipe fills a week, and those who have stopped smoking during the last 12 months) 
 If "yes":    
 a) How many cigarettes do you smoke per day?   
                                            a) less than 5   
                                            b) 5-14    
                                            c) 15 or more   
 If "no":    
 b) Have you been a smoker, but have stopped smoking more than a year ago?  
    
15. What has been your main work/occupation?   
 Please, write your answer here:   
 a) How many years have you been working in this occupation?:            years  
    
16. Have you now another work/occupation (other work/profession, studies,   
 unemployed, house-wife, retired, sickness pension etc.)?   
 Please, write your answer here:   
 a) if you have another work etc., since how many years?   
    
 In addition, questions about working outdoors or indoors, being exposed to   
 environmental tobacco smoke during childhood, and skiing habits   
 were asked in the Finnish version of the FinEsS questionnaire.  
    
Appendix 374
Appendix 3
Brief description of socio-economic classification by Statistics Sweden  
1      (11-12) Unskilled and semi-skilled workers 
2      (21-22) Skilled workers 
2 (33-36) Assistant non-manual employees 
3 (44-46) Intermediate non-manual employees 
4 (54-60) Employed and self-employed professionals, higher civil servants and executives 
5 (76-87) Self-employed (other than professionals) 
11-22 MANUAL WORKERS 
11 Unskilled employees in goods production: occupations involving the production of goods 
and normally requiring less than two years of post-comprehensive school education 
12 Unskilled employees in service production: occupations involving service production and 
normally requiring less than two years of post-comprehensive school education 
21 Skilled employees in goods production: occupations involving the production of goods and 
normally requiring two years or more of post-comprehensive school education 
22 Skilled employees in service production: occupations involving service production and 
normally requiring two years or more of post-comprehensive school education 
33-57 NON-MANUAL EMPLOYEES 
      33 Assistant non-manual employees, lower level: occupations normally requiring less than two           
years of post-comprehensive school education 
      34-35 Assistant non-manual employees, higher level: occupations normally requiring two, but      
not three, years of post-comprehensive school education 
      44-45 Intermediate non-manual employees: occupations normally requiring three, but not six, 
years of post-comprehensive school education 
      54-55 Professionals and other higher non-manual employees: occupations normally requiring at 
least six years of post-comprehensive school education 
      57 Upper-level executives: Upper-level executives in private enterprises or organisations with at 
least 100 employees or upper-level executives in public service 
60-87 SELF-EMPLOYED (including farmers) 
101-687 OTHERS: students, housewives, pensioners, unemployed, conscripts 
